Vape 10-Q 27 Apr 17 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jun. 30, 2016	Apr. 27, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	Vape Holdings, Inc.
Entity Central Index Key	1,455,819
Amendment Flag	false
Trading Symbol	plpe
Current Fiscal Year End Date	--09-30
Document Type	10-Q
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		657,936,872

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2016	Sep. 30, 2015
Current assets:
Cash	$ 5,410	$ 273,904
Accounts receivable	14,402	72,401
Inventory	22,806	194,937
Prepaid inventory	16,000	64,079
Other current assets	13,465	40,679
Deferred financing costs		107,908
Total current assets	72,083	753,908
Fixed assets, net of accumulated depreciation	54,461	118,327
Trademarks	123,150	123,150
Deferred financing costs, long-term		12,067
TOTAL ASSETS	249,694	1,007,452
Current liabilities:
Accounts payable	336,090	115,938
Accrued expenses	404,586	207,609
Customer deposits		1,275
Related party convertible notes payable	300,000
Convertible notes payable, net of unamortized discount of $287,064 and $153,096, respectively	251,961	522,396
Related party notes payable	15,000
Derivative liabilities	724,729	1,672,726
Warrant liability		31,401
Total current liabilities	2,032,366	2,551,345
Long term liabilities:
Convertible notes payable, long-term, net of unamortized discount of $17,167 and $655,607, respectively	182,833	300,156
Related party notes payable, long-term		265,000
Settlement liability	151,000
Other liabilities, long-term		12,235
Total liabilities	2,366,199	3,128,736
Commitments and contingencies
Stockholders' deficit:
Preferred stock, $0.00001 par value - 100,000,000 authorized; 500,000 outstanding at June 30, 2016 and September 30, 2015
Common stock, $0.00001 par value - authorized 1,000,000,000 shares; 444,595,793 issued at June 30, 2016, 433,555,168 outstanding at June 30, 2016 and 19,896,521 issued at September 30, 2015, 19,205,896 outstanding at September 30, 2015	4,335	192
Additional paid-in capital	30,284,264	26,412,800
Treasury stock, 1,025,625 and 690,625 shares at June 30, 2016 and September 30, 2015, respectively	(372,601)	(367,531)
Accumulated deficit	(32,032,503)	(28,166,745)
Total stockholders' deficit	(2,116,505)	(2,121,284)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 249,694	$ 1,007,452

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) (Unaudited) - USD ($)	Jun. 30, 2016	Sep. 30, 2015
Statement of Financial Position [Abstract]
Unamortized discount convertible notes payable, current	$ 287,064	$ 153,096
Unamortized discount convertible notes payable, non current	$ 17,167	$ 655,607
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares outstanding	500,000	500,000
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	444,595,793	19,896,521
Common stock, shares outstanding	433,555,168	19,205,896
Treasury stock, shares	1,025,625	690,625

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Income Statement [Abstract]
Revenue		$ 156,514	$ 282,331	$ 890,742	$ 1,084,233
Cost of revenue	[1]	385,705	157,140	1,040,420	604,668
Gross profit (loss)		(229,191)	125,191	(149,678)	479,565
Operating expenses:
Sales and marketing	[2]	84,246	188,925	342,618	554,263
Research and development		950	91,428	47,648	143,481
General and administrative	[3]	280,470	488,980	841,319	1,862,030
Total operating expenses		365,666	769,333	1,231,585	2,559,774
Operating loss		(594,857)	(644,142)	(1,381,263)	(2,080,209)
Other income (expense):
Interest expense		(408,419)	(112,690)	(1,727,304)	(284,168)
Interest expense - related party		(4,777)	(4,020)	(13,793)	(156,170)
Change in derivative liabilities		2,579,283	331,724	452,425	2,156,203
Gain on settlement					625,461
Loss on debt extinguishment, net			(6,924)		(26,905)
Excess of fair value of embedded conversion features		(136,527)		(1,195,023)
Total other income (expense), net		2,029,560	208,090	(2,483,695)	2,314,421
Income (loss) before provision for income taxes		1,434,703	(436,052)	(3,864,958)	234,212
Provision for income taxes				800	2,210
Net income (loss)		$ 1,434,703	$ (436,052)	$ (3,865,758)	$ 232,002
Net loss available to common shareholders:
Income (loss) per common share - basic		$ 0.01	$ (0.04)	$ (0.02)	$ 0.06
Income (loss) per common share - diluted		$ 0	$ (0.04)	$ (0.02)	$ 0.05
Weighted average shares - basic		215,717,808	11,925,400	220,677,405	11,253,868
Weighted average shares - diluted		1,097,384,088	11,925,400	220,677,405	13,874,926
[1]	Stock-based compensation was $0 and $2,075, and $0 and $41,408 for the three and nine months ended June 30, 2016 and 2015, respectively.
[2]	Stock-based compensation was $0 and $15,200, and $34,800 and $110,167 for the three and nine months ended June 30, 2016 and 2015, respectively.
[3]	Stock-based compensation was $0 and $126,250, and $128,597 and $529,799 for the three and nine months ended June 30, 2016 and 2015, respectively.

Consolidated Statements of Ope5

Consolidated Statements of Operations (Parenthetical) (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Stock-based compensation			$ 131,708	$ 969,577
Cost of revenue [Member]
Stock-based compensation	$ 0	$ 2,075	0	41,408
Sales and marketing [Member]
Stock-based compensation	0	15,200	34,800	110,167
General and administrative [Member]
Stock-based compensation	$ 0	$ 126,250	$ 128,597	$ 529,799

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit (Unaudited) - 9 months ended Jun. 30, 2016 - USD ($)	Total	Common Stock to be Issued	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Prepaid Stock-based Compensation	Treasury Stock	Series A Preferred stock
Balance at Sep. 30, 2015	$ (2,121,284)		$ 192	$ 26,412,800	$ (28,166,745)		$ (367,531)
Balance, shares at Sep. 30, 2015			19,205,896					500,000
Conversion of notes payable and accrued interest	3,707,140		$ 4,076	3,703,064
Conversion of notes payable and accrued interest, shares			407,602,767
Conversion of unpaid wages	95,708		$ 41	95,667
Conversion of unpaid wages, shares			4,138,888
Common stock issued for services	31,689		$ 14	31,675
Common stock issued for services, shares			1,442,617
Common stock issued for bonuses	36,000		$ 15	35,985
Common stock issued for bonuses, shares			1,500,000
Surrender of common stock			$ (3)	5,073			(5,070)
Surrender of common stock, shares			(335,000)
Net loss	(3,865,758)				(3,865,758)
Balance at Jun. 30, 2016	$ (2,116,505)		$ 4,335	$ 30,284,264	$ (32,032,503)		$ (372,601)
Balance, shares at Jun. 30, 2016			433,555,168					500,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net income (loss)	$ (3,865,758)	$ 232,002
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	106,967	49,990
Accretion of debt discounts	1,536,858	159,071
Excess of fair value of embedded conversion features	1,195,023
Fair value in excess of stock issued for conversion of notes payable and accrued interest		147,632
Gain on change in derivative and warrant liabilities	(483,826)	(2,156,203)
Gain on settlement		(625,461)
Forbearance and assignment settlements	190,718
Loss on debt extinguishments, net		19,981
Common stock issued for services	31,689	36,769
Stock-based compensation	131,708	969,577
Changes in operating assets and liabilities:
Accounts receivable	57,999	(36,202)
Inventory	220,210	(57,901)
Other assets	27,214	(20,496)
Accounts payable	220,152	209,680
Accrued expenses	128,903	136,148
Net cash used in operating activities	(502,143)	(935,413)
Cash flows from investing activities:
Capital expenditures	(43,101)	(64,895)
Purchase of trademarks and pending patents		(9,105)
Net proceeds from settlement		62,930
Net cash used in investing activities	(43,101)	(11,070)
Cash flows from financing activities:
Net proceeds from issuance of convertible notes payable	312,150	1,195,000
Net proceeds from issuances of related party convertible notes payable	50,000
Repayments on convertible notes payable	(85,400)	(40,000)
Repayments on related party convertible notes payable		(50,000)
Repayments on related party notes payable		(72,828)
Net cash provided by financing activities	276,750	1,032,172
Net change in cash	(268,494)	85,689
Cash, beginning of period	273,904	48,370
Cash, end of period	5,410	134,059
Cash paid during the period for:
Interest		18,788
Taxes	800	2,209
Non-cash investing and financing activities:
Conversion of notes payable and accrued interest	3,707,140	460,233
Conversion of related party notes payable and accrued interest		341,747
Original issue discount recorded with convertible note payable		257,489
Beneficial conversion feature recorded with convertible notes payable		252,079
Beneficial conversion feature recorded with related party convertible note payable		$ 5,410

Description of Business and Sum

Description of Business and Summary of Significant Accounting Policies	9 Months Ended
	Jun. 30, 2016
Description of Business and Summary of Significant Accounting Policies [Abstract]
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BUSINESS Vape Holdings, Inc. (“VAPE,” the “Company,” “we,” “us,” “our,” “our company”) is a holding company with its primary focus in the manufacturing and distribution of healthy and sustainable vaporization products. The Company designs, markets and distributes ceramic vaporization products under a unique brand. The Company has introduced a nonporous, non-corrosive, chemically inert medical-grade ceramic vaporization element as a healthy, sustainable alternative to traditional titanium and quartz vaporization materials, as well as lower-grade ceramic found in traditional electronic cigarettes and vaporizers. This material can be used for a wide range of applications, including stand-alone vaporization products and “E-cigs.” Electronic cigarettes come in a variety of designs ranging from those that look vastly like traditional cigarettes, to larger vaporizer units which are capable of vaporizing liquid with varying viscosity. The process of vaporization is believed to eliminate the smoke, tar, ash, and other byproducts of traditional smoking by utilizing lower temperatures in a controlled electronic environment. HIVE CERAMICS HIVE Ceramics (“HIVE”) is the premier brand under the VAPE umbrella. HIVE manufactures and distributes a proprietarily blended ceramic vaporization element for torched, electronic and portable vaporizers with countless design and product crossover capabilities in existing and emerging markets. HIVE is dedicated to bringing the healthiest and cleanest vaporization experience possible to the market. The HIVE product line currently consists of over 15 distinct ceramic elements, including the 2 piece domeless, domeless direct inject, and HIVE’s signature domeless elements covering 10mm, 14mm and 18mm applications as well as regular elements, the HIVE Flower Cup, the HIVE Carb Cap, HIVE Stinger Dabber, the 14mm HIVE x Quave - Club Banger, the HIVE x Brothership Honey Bucket and the HIVE x D-Nail 16mm and 20mm attachments. The Company intends to rely on a combination of trademark, copyright, trade secret and patent laws in the United States as well as confidentiality procedures and contractual provisions to protect future proprietary technology and its brands, as they are developed. The Company has created or acquired and continues in the process of creating and/or acquiring proprietary vaporizers and e-cigarettes, and various trademarks, patents and copyrights for brands which are developed or in development. The Company is actively engaged in improving and expanding lines of branded products through business alliances and acquisitions, as well as developing its branded retail business expansion. VAPE and its business units are organized and directed to operate strictly in accordance with all applicable state and federal laws. REVIVAL PRODUCTS On December 28, 2015, the Company created a new wholly-owned subsidiary, Revival Products, LLC (“Revival”), which is in the business of portable vaporization devices. Revival will sell disposable cartridges that complement HIVE Ceramic’s product lines utilizing its sales and distribution channels and via its own designated e-commerce site at www.revivalvapes.com VAPE is organized and directed to operate strictly in accordance with all applicable state and federal laws. GOING CONCERN VAPE’s consolidated financial statements reflect a net loss of $3,865,758 during the nine months ended June 30, 2016. As of June 30, 2016, we had cash of $5,410 and a working capital deficit of $1,960,283. VAPE has suffered an accumulated deficit of $32,032,503 and during the nine months ended June 30, 2016, the Company took steps to cease its Offset, HIVE Glass and HIVE Supply, and Revival business lines. The Company also closed its “THE HIVE” retail store in order to reduce overhead costs and focus on HIVE Ceramics. Moreover, the Company curtailed its exploration into providing real estate, management and consulting solutions to the legal cannabis industry in states where such cannabis cultivation and extraction is legal. The Company was never able to execute on any of these plans and ultimately determined that the Company’s capital reserves for such projects as well as the risks inherent in each project due to the current regulatory environment surrounding the cannabis industry made this line of business too difficult to pursue. All of which have resulted in losses and opportunity costs. In addition, the ongoing need to obtain financing to fund operations also raise substantial doubt about the ability of Vape to continue as a going concern. Management is skeptical that VAPE will obtain funding for operations for the foreseeable future; there are no assurances that the Company will obtain such funding. VAPE’s financial statements do not include any adjustments to reflect the possible effects on recoverability and classification of assets or the amounts and classification of liabilities that may result from the inability to continue as a going concern. See Note 10 for subsequent events regarding financing activities. VAPE is currently involved in litigation with 1 convertible promissory note holder seeking the specific performance of VAPE’s issuance of shares underlying denied conversion notices. VAPE is also currently negotiating with a second noteholder threatening similar litigation. VAPE shall vigorously defend any lawsuits; however, if these noteholders are allowed to convert their respective notes VAPE shareholders will experience substantial dilution.

Accounting Policies and Basis o

Accounting Policies and Basis of Presentation	9 Months Ended
	Jun. 30, 2016
Accounting Policies and Basis of Presentation [Abstract]
ACCOUNTING POLICIES AND BASIS OF PRESENTATION	NOTE 2. ACCOUNTING POLICIES AND BASIS OF PRESENTATION BASIS OF PRESENTATION The accompanying unaudited interim consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the SEC. Certain information and disclosures normally included in the annual financial statements prepared in accordance with the accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these consolidated financial statements have been included. Such adjustments consist of normal recurring adjustments. The current results are not an indication of the full year. CONSOLIDATION The consolidated financial statements include the assets, liabilities, and operating results of the Company and its wholly-owned subsidiaries, Revival and Nouveau after elimination of all material inter-company accounts and transactions. USE OF ESTIMATES The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include losses for warrant contingencies and the valuation of conversion features in notes. FAIR VALUE OF FINANCIAL INSTRUMENTS Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants as of the measurement date. Applicable accounting guidance provides an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors that market participants would use in valuing the asset or liability. There are three levels of inputs that may be used to measure fair value: Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 - Include other inputs that are directly or indirectly observable in the marketplace. Level 3 - Unobservable inputs which are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Derivative instruments include the convertible notes payable warrant liability (Level 2). Derivative instruments are valued using standard calculations/models that are primarily based on observable inputs, including volatilities and interest rates. Therefore, derivative instruments are included in Level 2. Fair-value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2016 and September 30, 2015. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, prepaid expenses, accounts payable, accrued liabilities, and notes payable. Fair values for these items were assumed to approximate carrying values because of their short-term nature or they are payable on demand. The following table presents the Company’s fair value hierarchy for assets measured at fair value on a recurring basis at June 30, 2016: Level 1 Level 2 Level 3 Total Assets Cash and cash equivalents $ 5,410 $ - $ - $ 5,410 Total assets measured at fair value $ 5,410 $ - $ - $ 5,410 Liabilities Derivative instruments $ - $ 724,729 $ - $ 724,729 Total liabilities measured at fair value $ - $ 724,729 $ - $ 724,729 The following table presents the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at September 30, 2015: Level 1 Level 2 Level 3 Total Assets Cash and cash equivalents $ 273,904 $ - $ - $ 273,904 Total assets measured at fair value $ 273,904 $ - $ - $ 273,904 Liabilities Derivative instruments $ - $ 1,672,726 $ - $ 1,672,726 Total liabilities measured at fair value $ - $ 1,672,726 $ - $ 1,672,726 CONCENTRATION Credit Risk At times, the Company maintains cash balances at a financial institution in excess of the FDIC insurance limit. In addition, at we extend credit to customers in the normal course of business, after we evaluate the credit worthiness. The Company does not expect to take any unnecessary credit risks causing significant write-offs of potentially uncollectible accounts. Customers Two (2) customers accounted for 60% of our accounts receivable as of June 30, 2016. One (1) customer accounted for 37% of our accounts receivable as of September 30, 2015. The loss of these customers would have a significant impact on the Company’s financial results. Suppliers Two (2) suppliers accounted for 100% and 98% of our purchases during the three and nine months ended June 30, 2016. Two (2) suppliers 68% and 70% of our purchases during the three and nine months ended June 30, 2015. The loss of these suppliers would have a significant impact on the Company’s financial results. REVENUE RECOGNITION The Company recognizes revenues from product sales when (a) persuasive evidence that an agreement exists; (b) the products have been delivered; (c) the prices are fixed and determinable and not subject to refund or adjustment; and (d) collection of the amounts due is reasonably assured. Revenue is generally recorded when sales orders are shipped. INVENTORY Inventory is valued at the lower of cost or market, as determined primarily by the average cost inventory method, and are stated using the first-in, first-out (FIFO) method. Management will record a provision for loss for obsolete or slow moving inventory to reduce carrying amounts to net realizable value. We purchase product sourced from China which we are required to pay 50% upon placing the order. Amounts paid for products, which have not been received, are recorded as prepaid inventory. There are no amounts paid which are in dispute or considered impaired. FIXED ASSETS Fixed assets are recorded at cost and depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The estimated life of tooling related to our ceramic products is two (2) years. The estimated life of our leasehold improvements is the lesser of the term of the related lease and useful life of the asset. IMPAIRMENT OF LONG-LIVED AND PURCHASED INTANGIBLE ASSETS The Company has adopted Accounting Standards Codification (“ASC”) 350 “Intangibles - Goodwill and Other.” The Statement requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undercounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 350 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell. Long-lived assets, such as fixed assets and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the asset is measured by comparison of its carrying amount to undiscounted future net cash flows the asset is expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the asset exceeds its fair market value. Estimates of expected future cash flows represent management’s best estimate based on currently available information and reasonable and supportable assumptions. Any impairment recognized is permanent and may not be restored. During the three and nine months ended June 30, 2016 and 2015, the Company did not record any impairment of its trademarks as its expected future cash flows are in excess of their carrying amounts. RESEARCH AND DEVELOPMENT Research and development costs are expensed as incurred. The costs of materials and equipment that will be acquired or constructed for research and development activities, and that have alternative future uses, both in research and development, marketing or sales, will be classified as fixed assets and depreciated over their estimated useful lives. To date, research and development costs include the research and development expenses related to prototypes of the Company’s products. During the three and nine months ended June 30, 2016 and 2015, research and development costs were $950 and $91,428, and $47,648 and $143,481, respectively. CONVERTIBLE DEBT Convertible debt is accounted for under the guidelines established by ASC 470-20 “Debt with Conversion and Other Options.” ASC 470-20 governs the calculation of an embedded beneficial conversion, which is treated as an additional discount to the instruments where derivative accounting (explained below) does not apply. The amount of the value of warrants and beneficial conversion feature may reduce the carrying value of the instrument to zero, but no further. Many of the conversion features embedded in the Company’s notes are variable and are adjusted based on a discount to market prices which could cause an unlimited number of common stock to be issued. In these cases, we record the embedded conversion feature as a derivate instrument, at fair value. The embedded conversion features are recorded as discounts when the notes become convertible. The excess of fair value of the embedded conversion feature over the carrying value of the debt is recorded as an immediate charge to operations. Each reporting period, the Company will compute the estimated fair value of derivatives and record changes to operations. The discounts relating to the initial recording of the derivatives or beneficial conversion features are accreted over the term of the debt using the effective interest method. Notes with cash payment penalties are recorded over the six month term of the note. The Company has lost the ability to increase the share reserves due to the significantly increased outstanding held by convertible noteholders and a shareholder vote is required to increase the authorized amount of shares the Company may issue. Further, the combination of limited capital and depleted share reserves have severely damaged the Company’s ability to find continued finance, properly run the Company, and proceed with business to include any mergers or acquisitions or any transactions that would require available stock. DERIVATIVE FINANCIAL INSTRUMENTS Derivative financial instruments, as defined in ASC 815, “Accounting for Derivative Financial Instruments and Hedging Activities”, consist of financial instruments or other contracts that contain a notional amount and one or more underlying (e.g. interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets. The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company has issued financial instruments including senior convertible notes payable and freestanding stock purchase warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by ASC 815, in certain instances, these instruments are required to be carried as derivative liabilities, at fair value, in our consolidated financial statements. The Company estimates the fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered to be consistent with objectively measuring fair values. In selecting the appropriate technique, consideration is given to, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex derivative instruments, such as free-standing warrants, the Company generally uses the Black-Scholes option valuation technique because it embodies all of the requisite assumptions (including trading volatility, estimated terms and risk free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock, which has a high-historical volatility. Since derivative financial instruments are initially and subsequently carried at fair values, the Company’s operating results will reflect the volatility in these estimate and assumption changes. EARNINGS (LOSS) PER COMMON SHARE Basic earnings (loss) per common share is computed by dividing net income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing net income available to common shareholders by the combination of dilutive common share equivalents, comprised of shares issuable under the Company’s share-based compensation plans and the weighted-average number of common shares outstanding during the reporting period. Dilutive common share equivalents include the dilutive effect of in-the-money share equivalents, which are calculated, based on the average share price for each period using the treasury stock method. Under the treasury stock method, the exercise price of an award, if any, the amount of compensation cost, if any, for future service that the Company has not yet recognized, and the estimated tax benefits that would be recorded in paid-in capital, if any, when an award is settled are assumed to be used to repurchase shares in the current period. In the event of losses, such common share equivalents are excluded as their effects are antidilutive. The following is a summary of outstanding securities which have been included in the calculation of diluted net income per share and reconciliation of net income to net income available to common stock holders for the three months ended June 30, 2016: For the June 30, Weighted average common shares outstanding used in calculating basic earnings per share 215,717,808 Effect of preferred stock 500,000 Effect of convertible notes payable 881,166,280 Weighted average common and common equivalent shares used in calculating diluted earnings per share 1,097,384,088 Net income as reported $ 1,434,703 Add - interest on convertible notes payable 408,419 Net income available to common stockholders $ 1,843,122 The following is a summary of outstanding securities that would have been included in the calculation of diluted shares outstanding since the exercise prices did not exceed the average market value of the Company’s common stock if the Company generated net income for the nine months ended June 30, 2016: For the June 30, 2016 Series A Preferred stock 500,000 Convertible notes 881,166,280 881,666,280 The Company excluded 110,000 options from the computation for the nine months ended June 30, 2015, as their exercise prices were in excess of the average closing market price of the Company’s common stock, causing their effects to be anti-dilutive using the treasury stock method. During the three months ended June 30, 2015, no options would have been included had the Company generated net income in the computation of dilutive shares outstanding using the treasury-stock method since the exercise prices exceeded the average market value of the Company’s common stock. The following is a summary of outstanding securities which have been included in the calculation of diluted net income per share and reconciliation of net income to net income available to common stock holders for the nine months ended June 30, 2015: For the June 30, Weighted average common shares outstanding used in calculating basic earnings per share 11,253,868 Effect of preferred stock 500,000 Effect of convertible notes payable 1,924,046 Effect of options and warrants 197,012 Weighted average common and common equivalent shares used in calculating diluted earnings per share 13,874,926 Net income as reported $ 232,002 Add - interest on convertible notes payable 427,240 Net income available to common stockholders $ 659,242 STOCK-BASED COMPENSATION ASC 718, “Share-Based Payment” requires that compensation cost related to share-based payment transactions be recognized in the consolidated financial statements. Share-based payment transactions within the scope of ASC 718 include stock options, restricted stock plans, performance-based awards, stock appreciation rights, and employee share purchase plans. The Company adopted ASC 718, which requires disclosure of the fair value and other characteristics of stock options and more prominent disclosure about the effects of an entity’s accounting policy decisions with respect to stock-based compensation on reported net loss. The Company has reflected the expense of such stock based compensation based on the fair value at the grant date for awards consistent with the provisions of ASC 718. In connection with the adoption of ASC 718, the fair value of our share-based compensation has been determined utilizing the Black-Scholes pricing model. The fair value of the options granted is amortized as compensation expense on a straight line basis over the requisite service period of the award, which is generally the vesting period. The fair value calculations involve significant judgments, assumptions, estimates and complexities that impact the amount of compensation expense to be recorded in current and future periods. Upon option exercise, the Company issues new shares of stock. The following weighted average variables were used in the Black Scholes model for all option issuances valued during the nine months ended June 30, 2016 and 2015: Nine Months Stock Price at Dividend Exercise Risk Free Volatility Average 2016 n/a n/a n/a n/a n/a n/a 2015 $ 0.73 n/a $ 0.73 2.2 % 380 % 10.0 The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of Emerging Issues Task Force (“EITF”) 96-18, “Accounting for Equity Instruments That are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services”, codified into ASC 505-50. The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement. Prepaid stock-based compensation is recorded when shares are issued based on the value on the grant date, but vest over the contractual period at which time the prorated expense will be recorded. RECENT ACCOUNTING PRONOUNCEMENTS In April 2015, the FASB issued Accounting Standard Update (“ASU”) 2015-03 Simplifying the Presentation of Debt Issuance Costs. This update requires capitalized debt issuance costs to be classified as a reduction to the carrying value of debt rather than a deferred charge, as is currently required. This update will be effective for the Company for all annual and interim periods beginning after December 15, 2015 and is required to be adopted retroactively for all periods presented, and early adoption is permitted. The Company adopted the policy during the quarter ending March 31, 2016. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers”, which supersedes most of the current revenue recognition requirements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for these goods or services. New disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers are also required. This guidance is effective for the Company in the first quarter of fiscal year 2018 and early application is not permitted. Entities must adopt the new guidance using one of two retrospective application methods. The Company is currently evaluating the standard but does not expect it to have a material impact on our financial position, results of operations or cash flows. In August 2014, the FASB issued ASU 2014-15, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued.2 An entity must provide certain disclosures if “conditions or events raise substantial doubt about the entity’s ability to continue as a going concern.” The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Financial Accounting Standards Board issues Accounting Standard Updates (“ASUs”) to amend the authoritative literature in Accounting Standards Codification (“ASC”). There have been a number of ASUs to date that amend the original text of ASC. The Company believes those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company. RISKS AND UNCERTAINTIES Although forward-looking statements in this Quarterly Report reflect our good faith judgment, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include without limitation those discussed under the heading “Risk Factors” below, as well as those discussed elsewhere in this Quarterly Report. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report. Readers are urged to carefully review and consider the various disclosures made in this Quarterly Report, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

Fixed Assets

Fixed Assets	9 Months Ended
	Jun. 30, 2016
Fixed Assets [Abstract]
FIXED ASSETS	NOTE 3. FIXED ASSETS The following is a summary of fixed assets as of June 30, 2016 and September 30, 2015: June 30, September 30, Molds and Tooling $ 219,115 $ 176,015 Leasehold improvements 29,795 29,795 Accumulated depreciation (194,449 ) (87,483 ) $ 54,461 $ 118,327 During the nine months ended June 30, 2016 and 2015, depreciation expense included in cost of revenue were $106,967 and $49,990, respectively.

Accrued Expenses

Accrued Expenses	9 Months Ended
	Jun. 30, 2016
Accrued Expenses [Abstract]
ACCRUED EXPENSES	NOTE 4. ACCRUED EXPENSES The following is a summary of accrued expenses as of June 30, 2016 and September 30, 2015: June 30, 2016 September 30, Accrued interest $ 139,929 $ 46,337 Accrued interest - related party 38,331 24,538 Accrued wages and taxes 223,224 112,322 Other 3,102 24,412 $ 404,586 $ 207,609 As of June 30, 2016, $25,000 for Kyle Tracey, $16,667 for Joe Andreae, $43,742 for Mike Cook, $36,382 for Allan Viernes, $38,048 for Benjamin Beaulieu, and $25,792 for Justin Braune are recorded in accrued wages.

Third Party Debt

Third Party Debt	9 Months Ended
	Jun. 30, 2016
Third Party Debt [Abstract]
THIRD PARTY DEBT	NOTE 5. THIRD PARTY DEBT CONVERTIBLE NOTES PAYABLE In connection with the Third Party Debt Conversions, each of the Company’s convertible noteholders is entitled to a “share reserve” per their agreements with the Company which entitle them to reserve a certain allotment of common stock out of the authorized but unissued common stock of the Company for future conversions of their notes. The Company is further obligated under the agreements to increase the Company’s authorized share count to accommodate for a sufficient amount of share reserves. Due to the declining market price of the Company’s common stock, the noteholders have reserve claims in excess of the common stock authorized at this time. The inability of the Company to meet its share reserve obligations may be considered a technical violation of their agreements with the noteholders but none of the noteholders have called a default under the terms of the notes at this time. The Company’s ability to issue common stock other than those presently allocated to noteholders is restricted during this time. The Company has lost the ability to increase the share reserves by written consent of shareholders due to the significantly increased outstanding held by convertible noteholders and a shareholder vote is required to increase the authorized amount of shares the Company may issue. Further, the combination of limited capital and depleted share reserves have severely damaged the Company’s ability to find continued financing, properly run the Company, and proceed with business to include any mergers or acquisitions or any transactions that would require available stock. The Company is currently involved in litigation with 1 noteholder seeking the specific performance of VAPE’s issuance of shares underlying denied conversion notices. VAPE is also currently negotiating with a second noteholder threatening similar litigation. If the noteholders are allowed to convert their respective notes VAPE shareholders will experience substantial dilution. The Company’s denial of the conversion notices has triggered a technical default on certain of its convertible notes and have presented amounts due as current liabilities other than those subsequently converted and began accruing interest at their default interest rates. Further, our funding partner may not commit to purchasing the balance of the notes currently outstanding due to the declining stock market price of the Company’s common stock. Securities Purchase Agreement On December 3, 2014, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an accredited investor (the “Investor”) pursuant to which the Company agreed to sell, and the Investor agreed to purchase, an unsecured convertible promissory note (the “Note”) in the principal amount of $560,000 less an original issue discount (“OID”) of $50,000 and transaction expenses of $10,000 for a total purchase price of $500,000. The Company also paid a finder’s fee in the amount of $25,000 in connection with this transaction, which was recorded as a discount to the note as it was paid from the proceeds. The closing under the Securities Purchase Agreement occurred on December 3, 2014. The Company received $475,000 net proceeds after transactions costs. On December 10, 2015, the Company and the Investor entered into a forbearance agreement regarding the Investor’s convertible note and added $105,000 to the principal and charged to interest expense during the three months ended December 31, 2015. On February 26, 2016, the note was assigned to an accredited investor and $21,874 was added to the principal balance and charged to interest expense during the three and six months ended March 31, 2016. We amortized $5,556 and $8,333, and $22,222 and $19,444 of the original issue discount to interest expense during the three and nine months ended June 30, 2016 and 2015, respectively. In addition, the Company recorded $45,940 in debt issuance costs as a discount on the note and amortized $5,106 and $7,657, and $20,418 and $17,866 to interest expense during the three and nine months ended June 30, 2016 and 2015, respectively. As of June 30, 2016, the Company had fully amortized the discounts. On August 26, 2015, the Company and Investor entered into an Amendment whereby the conversion rate of the note was amended to 55% of the lowest price of the prior fifteen (15) trading days and conversion floor removed which amendment was triggered by the dilutive issuances of the August 2015 convertible note financing thereby entitling Investor to the lowest conversion rate granted during the year ended September 30, 2015 per the terms of the Securities Purchase Agreement. On August 26, 2015, the Company recorded the note as a derivative liability at fair value of $830,921, a derivative discount of $332,666, and the excess in fair value of $498,254 to loss on debt extinguishment. The total loss on debt extinguishment on this note was $582,254. During the three and nine months ended June 30, 2016, the Company amortized $28,183 and $277,682 of the derivative discount to interest expense, recorded a loss (gain) on the change in fair value of the derivative liability of ($287,888) and $574,381, and allocated the fair value of $401,128 and $1,195,787 of the conversions below to additional paid-in capital and a reduction in the derivative liability, respectively. As of June 30, 2016, the derivative liability was $22,507. Between October 2015 and June 30, 2016, the Company issued the following conversions for payment towards Investor: Conversion Date Principal Converted Accrued Interest Converted Total Converted Conversion Rate Common Shares Issued October 8, 2015 $ 21,000 $ - $ 21,000 $ 0.012 1,818,182 October 16, 2015 18,900 - 18,900 $ 0.012 1,636,364 October 22, 2015 25,800 - 25,800 $ 0.011 2,333,786 October 29, 2015 22,460 - 22,460 $ 0.011 2,031,660 November 11, 2015 33,500 - 33,500 $ 0.007 4,649,549 November 18, 2015 24,000 - 24,000 $ 0.006 4,195,804 November 30, 2015 30,000 - 30,000 $ 0.005 5,741,627 December 11, 2015 22,000 - 22,000 $ 0.002 9,090,909 December 28, 2015 22,500 - 22,500 $ 0.002 9,297,521 January 7, 2016 20,000 - 20,000 $ 0.002 10,101,010 January 20, 2016 12,500 - 12,500 $ 0.001 10,330,579 February 2, 2016 13,200 - 13,200 $ 0.001 10,909,091 March 2, 2016 10,627 - 10,627 $ 0.001 10,169,800 March 10, 2016 11,184 - 11,184 $ 0.001 10,702,619 March 17, 2016 8,272 - 8,272 $ 0.001 6,539,200 March 29, 2016 22,797 - 22,797 $ 0.002 12,191,000 March 31, 2016 22,347 - 22,347 $ 0.002 11,950,000 April 4, 2016 25,140 - 25,140 $ 0.002 13,444,000 April 7, 2016 21,019 - 21,019 $ 0.002 11,240,000 April 13, 2016 35,664 - 35,664 $ 0.002 14,737,000 April 19, 2016 36,711 - 36,711 $ 0.002 15,170,000 April 20, 2016 18,244 - 18,244 $ 0.002 7,538,666 $ 477,865 $ - $ 477,865 185,818,367 As of June 30, 2016, there is $22,632 in accrued interest expense related to this note, and the Company recorded $2,255 and $14,156, and $21,094 and $32,511 in interest expense during the three and nine months ended June 30, 2016 and 2015, respectively. $2M Securities Purchase Agreement On February 10, 2015, the Company entered into a securities purchase agreement (the “February 2015 Securities Purchase Agreement”) with an accredited investor pursuant to which the Company agreed to sell, and the investor agreed to purchase, an unsecured convertible promissory note (the “$2M Note”) in the principal amount of $2,000,000 less an OID of $182,000 and transaction expenses of $10,000 for a total purchase price of $1,808,000. The closing under the February 2015 Securities Purchase Agreement occurred on February 10, 2015. During the year ended September 30, 2015, the Company received $800,000 toward the $2M Note with an original issue discount of $148,600 and transaction costs for net proceeds of $651,395. On February 23, 2016, the note was assigned to an accredited investor, the same accredited investor as the Security Purchase Agreement, and $36,038 was added to the principal balance and charged to interest expense during the three and six months ended March 31, 2016. On August 13, 2015, the Company entered into an Amendment, Waiver and Modification Agreement (the “Amendment”) to its $2M Securities Purchase Agreement and related Transaction Documents with Redwood Management, LLC including any designees and or assignees thereto. Under the terms of the Amendment, the parties agreed to reduce the $2,000,000 outstanding balance of the $2M Note to $800,000 to reflect the total amount funded under the note, to terminate the offsetting investor note securing the additional unfunded balance and to waive any past claims of default or offsetting interest on the $2M Note or investor note. In addition, the conversion rate of the note was amended to 55% of the lowest price of the prior fifteen (15) trading days and conversion floor removed which amendment was triggered by the dilutive issuances of the August 2015 convertible note financing thereby entitling Investor to the lowest conversion rate granted during the year ended September 30, 2015 per the terms of the $2M Securities Purchase Agreement. As a result, we expensed the unamortized discount of $40,000 to loss on debt extinguishment. On August 13, 2015, the carrying value on the note was $655,816, net of unamortized discounts of $94,184. The Company recorded the note as a derivative liability at fair value of $970,956, a derivative discount of $655,816, and the excess in fair value of $315,140 to loss on debt extinguishment. The total loss on debt extinguishment on this note was $369,324. During the three and nine months ended June 30, 2016, the Company amortized $0 and $472,628 of the derivative discount to interest expense, recorded a loss (gain) on the change in fair value of the derivative liability of ($296,142) and $27,730, and allocated the fair value of $123,179 and $1,056,544 of the conversions below as additional paid-in-capital and a reduction in the derivative liability, respectively. As of June 30, 2016, the derivative liability was fully extinguished due to its full conversion. The following is summary of conversions by the $2M Note holder (including its assignees) during the nine months ended June 30, 2016: Conversion Date Principal Converted Accrued Interest Converted Total Converted Conversion Rate Common Shares Issued October 1, 2015 $ 10,000 $ - $ 10,000 $ 0.015 675,676 October 5, 2015 10,000 - 10,000 $ 0.015 675,676 October 6, 2015 13,262 - 13,262 $ 0.014 961,000 October 7, 2015 10,000 - 10,000 $ 0.012 865,801 October 9, 2015 11,728 - 11,728 $ 0.012 1,011,000 October 9, 2015 10,000 - 10,000 $ 0.012 865,801 October 12, 2015 14,680 - 14,680 $ 0.012 1,271,000 October 13, 2015 11,601 - 11,601 $ 0.012 1,000,052 October 15, 2015 14,680 - 14,680 $ 0.012 1,271,000 October 19, 2015 17,400 - 17,400 $ 0.012 1,500,000 October 19, 2015 15,000 - 15,000 $ 0.012 1,298,701 October 20, 2015 16,650 - 16,650 $ 0.011 1,500,000 October 21, 2015 17,500 - 17,500 $ 0.012 1,515,152 October 23, 2015 20,000 - 20,000 $ 0.012 1,731,602 October 26, 2015 24,420 - 24,420 $ 0.011 2,200,000 October 29, 2015 26,640 - 26,640 $ 0.011 2,400,000 November 2, 2015 29,970 - 29,970 $ 0.011 2,700,000 November 2, 2015 20,000 - 20,000 $ 0.011 1,809,136 November 5, 2015 32,190 - 32,190 $ 0.011 2,900,000 November 10, 2015 28,800 - 28,800 $ 0.010 3,000,000 November 12, 2015 23,930 - 23,930 $ 0.007 3,323,611 November 17, 2015 16,500 - 16,500 $ 0.006 2,727,273 November 19, 2015 1,640 11,225 12,865 $ 0.006 2,316,013 November 23, 2015 23,111 - 23,111 $ 0.006 4,127,000 November 27, 2015 24,750 - 24,750 $ 0.006 4,500,000 December 2, 2015 18,450 - 18,450 $ 0.004 4,500,000 December 8, 2015 18,000 - 18,000 $ 0.004 5,000,000 December 11, 2015 13,368 - 13,368 $ 0.002 5,570,000 December 16, 2015 14,181 - 14,181 $ 0.002 5,860,000 December 22, 2015 15,488 - 15,488 $ 0.002 6,400,000 December 29, 2015 17,666 17,666 $ 0.002 7,300,000 May 31, 2016 27,495 - 27,495 $ 0.001 19,227,000 June 13, 2016 28,936 - 28,936 $ 0.001 20,235,000 June 21, 2016 22,254 - 22,254 $ 0.001 21,296,000 June 28, 2016 12,339 2,589 14,928 $ 0.001 16,964,625 $ 632,629 $ 13,814 $ 646,443 160,498,119 During the three and nine months ended June 30, 2016 and 2015, the Company amortized $0 and $17,600, and $30,713 and $22,400 of the original issue discount to interest expense, respectively. As of June 30, 2016, there is $35,319 in accrued interest expense related to this note and the Company recorded $7,617 and $10,111, and $16,209 and $14,500 in interest expense during the three and nine months ended June 30, 2016 and 2015, respectively. Convertible Note Financing On August 5, 2015, the Company entered into a series of convertible note financings with several accredited investors totaling an aggregate of $541,000 in aggregate proceeds raised less certain fees and costs as set forth in the financing documents known as the “August 2015 Notes”. The financing was disclosed on the Company’s Current Report on Form 8-K filed on August 11, 2015 and is incorporated herein by reference. The Company recorded an original issue discount of $12,500 along with these notes. On March 7, 2016, $112,000 of these notes were assigned to the same accredited investor previously mentioned and $7,806 was added to the principal balance and recorded as interest expense during the three and six months ended March 31, 2016. August 2015 Notes On August 5, 2015, the carrying value on the notes were $419,626, net of unamortized original issue discounts of $9,374. In six months when the note became convertible, the Company recorded the note as a derivative liability at fair value of $1,181,732, a derivative discount of $419,626, and the excess in fair value of embedded conversion feature of $762,106. The Company amortizes the derivative discount over the expected life of the related debt. During the three and nine months ended June 30, 2016, the Company amortized $205,284 and $313,020 of the derivative discount to interest expense and recorded a gain on the change in fair value of the derivative liability of $1,235,526 and $839,257. As of June 30, 2016, the derivative liability was $342,474. During the three and nine months ended June 30 2016, the Company amortized $2,764 and $5,890 of original issue discounts to interest expense. During the three and nine months ended June 30 2016, the Company amortized $17,964 and $53,891 of debt issuance costs to interest expense. As of June 30, 2016, $163,219 and $61,167 is classified as current and long-term on the accompanying consolidated balance sheet, net of total unamortized discounts of $105,381 and $13,833, respectively. As of June 30, 2016, there is $53,241 in accrued interest expense related to these notes and the Company recorded $23,807 and $46,944 in interest expense during the three and nine months ended June 30, 2016, respectively. Additional Funding Under August 2015 Note On December 15, 2015, an accredited investor provided the Company with $50,000 in additional proceeds under the same terms of their original convertible note with a term of two years. A one-time interest charge of $11,600 was added to the principal of the note. In six months when the note became convertible, the Company recorded the note as a derivative liability at fair value of $95,251, a derivative discount of $61,600, and the excess in fair value of $33,651 to excess of fair value of embedded conversion feature. The Company amortizes the derivative discount over the expected life of the related debt. During the three and nine months ended June 30, 2016, the Company amortized $3,422 and $3,422 of the derivative discount to interest expense and recorded a gain on the change in fair value of the derivative liability of $9,630 and $9,630, respectively. As of June 30, 2016, the derivative liability was $85,621.The Company also recorded $4,000 of debt issuance costs as a discount. During the three and nine months ended June 30, 2016, the Company amortized $500 and $1,000 of debt issuance costs to interest expense. As a result, as of June 30, 2016, $422 is classified as current on the accompanying consolidated balance sheet, net of total unamortized discounts of $61,178. As of June 30, 2016, there is default interest of $5,605 in accrued interest expense related to these notes and the Company recorded $3,757 and $5,605 during the three and nine months ended June 30, 2016, respectively. Assigned 2015 Notes On August 5, 2015, the carrying value on an assigned note was $112,000. In six months when the note became convertible, the Company recorded the note as a derivative liability at fair value of $400,722, a derivative discount of $112,000, and the excess in fair value of $288,722 to loss on debt extinguishment. During the three and nine months ended June 30, 2016, the Company amortized $74,667 and $112,000 of the derivative discount to interest expense and recorded a gain on the change in fair value of the derivative liability of $516,101 and $223,098, respectively. As of June 30, 2016, the derivative liability was fully extinguished due to its full conversion. During the three and nine months ended June 30, 2016, the Company amortized $0 and $8,571 of debt issuance costs to interest expense, respectively. During the nine months ended June 30, 2016, the Company enacted the following conversions: Conversion Date Principal Converted Accrued Interest Converted Total Converted Conversion Rate Common Shares Issued April 20, 2016 $ 16,117 $ - $ 16,117 $ 0.0024 6,660,000 April 25, 2016 46,349 - 46,349 $ 0.0029 15,900,000 May 5, 2016 37,744 - 37,744 $ 0.0025 15,250,000 May 18, 2016 19,597 1,594 21,191 $ 0.0020 10,413,268 $ 119,807 $ 1,594 $ 121,401 48,223,268 As of June 30, 2016, there is $12,562 in accrued interest expense related to these notes and the Company recorded $3,219 and $12,066 in interest expense during the three and nine months ended June 30, 2016, respectively. On August 12, 2015, the Company entered into an additional convertible note financing transaction with an accredited investor in the principal amount of $105,000 less fees and costs. The same accredited investor was assigned mentioned above was assigned this note and $20,000 was added to the principal balance and recorded as interest expense during the three and six months ended March 31, 2016. The closing under the financing occurred concurrently with the execution of the financing documents on August 12, 2015. The convertible note bears interest at the rate of 8% per annum and is convertible into common stock of the Company at any time after 180 days from issuance of the note at a conversion price per share equal to 58% of the average of the lowest trading price of the common stock in the thirteen (13) trading days immediately preceding the applicable conversion date. The Company has the option to prepay the convertible note in the first 180 days from closing subject to a prepayment penalty of 150% of principal plus interest. The maturity date of the convertible note is June 12, 2016 subject to the noteholder’s right to extend maturity an additional nine (9) month period. The Company recorded an original issue discount of $5,000 along with this note. In six months when the note became convertible, the Company recorded the note as a derivative liability at fair value of $110,669, a derivative discount of $103,000, and the excess in fair value of $7,669 to loss on debt extinguishment. During the three and nine months ended June 30, 2016, the Company amortized $51,500 and $85,833 of the derivative discount to interest expense and recorded a loss (gain) on the change in fair value of the derivative liability of ($237,246) and $38,179, respectively. As of June 30, 2016, the derivative liability was $148,847. During the three and nine months ended June 30, 2016, the Company amortized $1,000 and $4,000 of original issue discounts to interest expense, respectively. During the three and nine months ended June 30, 2016, the Company amortized $3,280 and $13,120 of debt issuance costs to interest expense, respectively. As a result, as of June 30, 2016, $107,833 is classified as long-term on the accompanying consolidated balance sheet, net of total unamortized discounts of $17,167. As of June 30, 2016, there is $16,366 in accrued interest expense related to these notes and the Company recorded $7,769 and $15,222 in interest expense during the three and nine months ended June 30, 2016, respectively. Subsequent to June 30, 2016, the note was fully converted as a result of the following conversions: Conversion Date Principal Converted Accrued Interest Converted Total Converted Conversion Rate Common Shares Issued July 8, 2016 $ 19,222 $ - $ 19,222 $ 0.0008 23,300,000 July 25, 2016 17,518 - 17,518 $ 0.0007 24,500,000 August 3, 2016 17,738 - 17,738 $ 0.0007 25,800,000 August 10, 2016 17,919 - 17,919 $ 0.0007 27,150,000 September 19, 2016 11,482 - 11,482 $ 0.0008 14,912,185 January 10, 2017 41,121 879 42,000 $ 0.0014 30,000,000 January 18, 2017 - 28,795 28,795 $ 0.0045 6,398,894 $ 125,000 $ 29,674 $ 154,674 152,061,079 The foregoing descriptions of the August 12, 2015 note financing and related documentation do not purport to be complete and are qualified in their entirety by reference to the full text of the documents, which are filed as exhibits to this Quarterly Report on Form 10-K/A and are incorporated herein by reference. April 2016 Note On April 19, 2016, the Company entered into an additional convertible note financing transaction with an accredited investor in the principal amount of $176,150 less fees and costs. The convertible note bears interest at the rate of 10% per annum and is convertible into common stock of the Company at any time after 180 days from issuance of the note at a conversion price per share equal to 55% of the lowest trading price in the thirteen (20) trading days immediately preceding the applicable conversion date. The Company has the option to prepay the convertible note in the first 180 days from closing subject to a prepayment penalty of 150% of principal plus interest. The maturity date of the convertible note is January 19, 2017. The Company recorded the prepayment penalty of $91,011 as a discount to the convertible note and will amortize it through the notes maturity date. During the three and nine months ended June 30, 2016, the Company recorded $45,505 and $45,505 of the discount to interest expense, respectively. As a result, as of June 30, 2016, $130,645 is classified as current on the accompanying consolidated balance sheet, net of total unamortized discounts of $45,505. As of June 30, 2016, there is $5,711 in accrued interest expense related to these notes and the Company recorded $5,711 and $5,711 in interest expense during the three and nine months ended June 30, 2016, respectively. In six months, if and when the note becomes convertible, the Company will record a derivative liability at fair value. EQUITY INVESTMENT BY THE INVESTOR On December 10, 2015, the Investor purchased $90,000 in common stock at a purchase price equal to 90% of the average of the closing prices of the common stock for the three (3) trading days immediately preceding the date that is 6 months from the date of the agreement. As of June 7, 2016, the Company entered into an agreement for proceeds of $90,000 to be recorded as a convertible note payable with a conversion feature of 55% of the lowest trading price for the prior twenty (20) days. The Company recorded the note as a derivative liability at fair value of $114,611, a derivative discount of $90,000, and the excess in fair value of $24,611 to excess of fair value of embedded conversion features. During the three and nine months ended June 30, 2016, the Company amortized $15,000 and $15,000 of the derivative discount to interest expense and recorded a loss on the change in fair value of the derivative liability of $10,670 and $10,670, respectively. As a result, as of June 30, 2016, $15,000 is classified as current on the accompanying consolidated balance sheet, net of total unamortized discounts of $75,000.

Related Party Debt

Related Party Debt	9 Months Ended
	Jun. 30, 2016
Related Party Debt [Abstract]
RELATED PARTY DEBT	NOTE 6. RELATED PARTY DEBT Related Party Note The Company had outstanding accounts payable balance to a related party (shareholder of the Company) in the amount of $15,000 as of September 30, 2013. This payable was converted into a note payable on December 7, 2013. The note payable bears interest of 6% per annum with a maturity date of December 1, 2016. As of June 30, 2016, there is $2,330 in accrued interest expense related to this note and the Company recorded $228 and $686 in interest expense related to this note during the three and nine months ended June 30, 2016. Related Party Convertible Notes Payable On December 10, 2015, the Company entered into two Secured Series B Preferred Stock Convertible Notes (the “Series B Notes”) for an aggregate principal of $300,000 including 1) $50,000 from Hive Ceramics, LLC in new capital to the Company and 2) an amended and restated note for Hive Ceramics LLC in the amount of $250,000 for capital previously contributed which is soon to be due and payable. The Series B Notes accrue interest at eight percent (8%) per annum, mature one (1) year from issuance and are secured by all of the assets and property of the Company. Upon the election of the noteholder, the Series B Notes are convertible into newly created Series B Preferred Stock on a one-for-one (1:1) basis into shares of common stock of the Company at a fixed price per share of $0.01. Concurrently, the Company filed a Certificate of Designation with the Delaware Secretary of State on the Series B Preferred Stock which provides, in pertinent part, for the following rights and privileges: Authorized Amount of Series B Preferred Stock Voting Rights Rank pari passu During the three and nine months ended June 30, 2016, the Company recorded $4,550 and $13,108 of interest expense related to the notes. As of June 30, 2016, $300,000 of the Series B Notes along with $36,001 of accrued interest are outstanding. The Board of Directors authorized the designation of the Series B Preferred Stock pursuant to the authority of the Certificate of Incorporation, which confers said authority on the Board, and the issuance of the Series B Notes pursuant to a unanimous written consent of the Board dated December 10, 2015. The value ascribed to the Series B Notes were based on the fixed conversion price of the instruments into common stock and such no beneficial conversion feature was recorded.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Jun. 30, 2016
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 7. COMMITMENTS AND CONTINGENCIES Office Lease As of June 30, 2016, the Company leases a 2,500 square foot office in Agoura Hills, California for approximately $2,500 per month which expires in December 2017. Warrant Liability The Company recorded the estimated settlement liability as of March 31, 2014 for the Warrant Shares issued and the Warrants that remain outstanding and unexercised that would be entitled to the same settlement based on the number of shares expected to be issued and the market price of the Company’s common stock on the dates of the actual settlements from $4.72 per share to $7.25 per share, and market price of the first settlement of $7.25 for the unsettled claims. The warrant liability expired during May 2016. As of June 30, 2016, the estimated liability is $0. The Company recorded a gain on the change in warrant liability of $31,401 and $2,156,203 during the nine months ended June 30, 2016 and 2015, respectively. Settlement of Company Legal Claims On December 15, 2014, the Company recorded a gain on settlement of $257,930 for a confidential settlement by and between the Company and certain shareholders and related parties as settlement for certain potential legal claims held by the Company. As a result of the settlement, the Company received net proceeds of $62,930 and vendor credits of $200,000 during the three months ended December 31, 2014. A total of $325,000 in vendor credits has been received in connection with the settlement and no further credits will be given. In January 2015, the Company received 440,625 shares from the settlement that was assigned to officers of the Company. The officers decided it was in the best interest of the Company to return these shares to the Company to be used for future strategic issuances. Accordingly, the 440,625 shares valued at $367,531 were recorded as treasury stock as of March 31, 2015. The Company recorded a gain on settlement of $0 and $0, and $0 and $625,461 during the three and nine months ended June 30, 2016 and 2015, respectively. Settlement Liability On or about December 1, 2016, the Company learned that LG Capital Funding, LLC (“LG Capital”), a plaintiff in a lawsuit pending in New York against the Company (Case 1:16-cv-02217-CBA-LB), obtained a judgment in the amount of $151,000. On or about December 10, 2016, the Company learned that LG Capital had placed a judgment lien on the Company’s operating account. The effect of the lien was that the Company’s operating account was frozen for an amount twice the judgment, or approximately $300,000. In or around December of 2016 and continuing into early January 2017, GHS Investments, LLC, a Nevada limited liability company (“GHS”) and LG Capital negotiated a transaction whereby GHS purchased the rights to the LG Capital Convertible Promissory Note and/or the right to collect on the LG Capital judgment. On or about January 10, 2017, GHS and the Company entered into a Convertible Promissory Note in the amount of $161,000 (the “GHS Convertible Note”) which represented that amount paid by GHS to LG Capital. The GHS Convertible Note carries a 10% interest rate, is due on October 15, 2017 and is convertible into common stock of the Company at a 45% discount off the lowest trading price for the Company’s common stock during the 20 trading days immediately preceding the conversion date. As of June 30, 2016, the Company recorded a settlement liability of $151,000.

Stockholders' Deficit

Stockholders' Deficit	9 Months Ended
	Jun. 30, 2016
Stockholders' Deficit [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 8. STOCKHOLDERS’ DEFICIT COMMON STOCK On November 27, 2013, the Board and shareholders approved an increase in the authorized number of shares of common and preferred stock which may be issued by the Company to 1,000,000,000 shares and 100,000,000 shares, respectively. On December 3, 2013, the certificate of amendment was filed with the Secretary of State of Delaware to reflect the increase in authorized. PREFERRED STOCK On April 1, 2014, the Board formally approved the filing of a Preferred Stock Designation in connection with the commitment of 500,000 Series A Shares to HIVE on March 27, 2014 pursuant to its authority to issue blank check preferred stock as provided in the Company’s Certificate of Incorporation. Per the Certificate of Designation (the “Designation”), there are 100,000,000 shares of preferred stock authorized by the Company’s Certificate of Incorporation. The Company is authorized to issue 500,000 shares of Series A Shares pursuant to the Designation. As provided in the Designation (and as set forth in the HIVE Asset Purchase Agreement), Series A Shares are entitled to vote at a 15-1 ratio to Common Stock. Each share of preferred stock shall initially be convertible into one share of common stock (500,000 shares of common stock in the aggregate). On the two year anniversary of the transaction of HIVE, the preferred stock conversion ratio shall be adjusted as follows: a one-time pro rata adjustment of up to ten-for-one (10-1) based upon the Company generating aggregate gross revenues over the two years of at least $8,000,000 (e.g. If the Company generates only $4,000,000 in aggregate gross revenues over the two year period then the convertible ratio will adjust to 5-1). In no event will the issuance convert into more than 5,000,000 shares of common stock of the Company. On June 19, 2014, the Company formally issued the 500,000 Series A Shares to HIVE. The value ascribed to the Series A Shares was based on the historical costs of the assets acquired on March 27, 2014 from HIVE since the transfer of assets was made among entities under common control. On December 10, 2015, the Company approved the filing of a Preferred Stock Designation for up to 30,000,000 shares of Series B Preferred Stock. No Series B Preferred Stock are issued or outstanding. See discussion of designation of Series B Preferred Stock in Note 6. COMMON STOCK ISSUED FOR ACCRUED WAGES On October 22, 2015, the Company’s Board of Directors issued 2,083,333 shares of restricted common stock to Kyle Tracey at $0.024 per share for payment of $50,000 in accrued wages. On October 22, 2015, the Company’s Board of Directors issued 555,555 shares of restricted common stock to Joe Andreae at $0.024 per share for payment of $13,333 in accrued wages. On October 22, 2015, the Company’s Board of Directors issued 1,250,000 shares of restricted common stock to Michael Cook at $0.024 per share for payment of $3,000 in accrued wages. In February 2016, Justin Braune elected to take $15,000 of wages as common stock. The shares will formally be issued once the debt conversions and capital structure restrictions have been resolved. On March 31, 2016, the Company’s Board of Directors issued 250,000 shares of restricted common stock to Justin Braune at $0.009 per share for payment of $2,375 in accrued wages. To date, the Company has issued but not delivered 3,000,000 shares of common stock to Justin Braune in accrued wages. The Company and Justin Braune, through Mr. Braune’s counsel, are attempting to negotiate a resolution of Mr. Braune’s assertions that the Company breached its agreements with Mr. Braune. COMMON STOCK ISSUED FOR BONUSES On October 22, 2015, the Company’s Board of Directors issued bonus stock grants of 600,000 shares of restricted common stock each to Allan Viernes and Benjamin Beaulieu at $0.024 per share. In addition, the Company issued 300,000 shares of restricted common stock to employees at $0.024 per share. These issuances were based on the fair market value on the date of issuance immediately vested and resulted in $36,000 being charged to general and administrative expense during the three months ended December 31, 2015. On October 22, 2015, the Company’s Board of Directors issued bonus stock grants of 1,250,000 shares of restricted common stock an outside sales consultant at $0.024 per share. The issuance was based on the fair market value on the date of issuance immediately vested and resulted in $30,000 being charged to sales and marketing expense during the three months ended December 31, 2015. COMMON STOCK ISSUED FOR SERVICES On November 25, 2015, the Company’s Board of Directors issued stock grants of 49,760 shares of restricted common stock a business development consultant at $0.011 per share. These issuances were based on the fair market value on the date of issuance immediately vested and resulted in $547 being charged to general and administrative expense during the three months ended December 31, 2015. On December 23, 2015, the Company’s Board of Directors issued stock grants of 142,857 shares of restricted common stock a business development consultant at $0.008 per share. These issuances were based on the fair market value on the date of issuance immediately vested and resulted in $1,143 being charged to general and administrative expense during the three months ended December 31, 2015. COMMON STOCK SURRENDERED On October 22, 2015, Joe Andreae surrendered 130,000 shares of restricted common stock valued at $3,120 and were recorded as treasury stock. In addition, on October 22, 2015, an employee also surrendered 30,000 shares valued at $360, which was recorded as treasury stock. On December 20, 2015, Kyle Tracey surrendered 130,000 shares of restricted common stock valued at $1,170 and were recorded as treasury stock. On December 21, 2015, the Allan Viernes and Benjamin Beaulieu each surrendered 30,000 shares of restricted common stock valued at $420, which was recorded as treasury stock. WARRANTS The table below summarizes the Company’s warrant activity during the nine month period ended June 30, 2016: Shares Weighted Average Weighted Average Remaining Contractual Term Aggregate Intrinsic Warrants outstanding at September 30, 2015 1,184,726 $ 0.114 0.9 $ 739,812 Warrants issued - - Warrants exercised - - Cancelled/forfeited/expired (1,184,726 ) $ 0.114 - - Warrants outstanding at June 30, 2016 - $ - - $ - The Company’s warrants above are accounted for as derivative liabilities in the accompanying consolidated balance sheets.

Intellectual Property

Intellectual Property	9 Months Ended
	Jun. 30, 2016
Intellectual Property [Abstract]
INTELLECTUAL PROPERTY	NOTE 9. INTELLECTUAL PROPERTY The Company plans to rely on a combination of trademark, copyright, trade secret and patent laws in the United States as well as confidentiality procedures and contractual provisions to protect future proprietary technology and its brands, as they are developed. The Company has begun to execute on this plan with the acquisition of the patent pending HIVE Ceramic vaporization product and the HIVE trademark as well as several pending trademark applications. The Company intends to continue to create or acquire proprietary vaporizers and e-cigarettes, and various trademarks, patents and/or copyrights for brands which are developed. TRADEMARKS On March 27, 2014, the Company and Stone Arch Studio, LLC entered into a Trademark Assignment Agreement whereby the Company acquired all right, title, priority and interest to the HIVE trademark U.S. Registration No. 44513069 as registered with the U.S. Patent and Trade Office (“USPTO”). This acquisition further protects the Company’s HIVE Ceramics brand vaporization line. In addition, the Company has filed for trademark protection with the USPTO on several additional trademarks and tradenames to be utilized by the Company in the future as the marks register. As of June 30, 2016, the Company has capitalized $123,150 in costs related to the trademarks. PATENTS On March 27, 2014, the Company formally closed its acquisition of the patent pending HIVE Ceramics vaporization technology. The Company has already begun exploiting this technology and intends to prosecute the patent application to completion. As of June, 2016, the Company has no patent costs capitalized. The Company is engaged in developing proprietary rights of the type that may be awarded patents for enhancements to its core HIVE product line as well as proprietary rights in related product lines. The Company also expects that from time to time it is in discussions to acquire additional patented technology from third parties to further grow and develop branded product lines in the vaporization market. See Note 1 regarding BetterChem unwind and rights to related patents.

Subsequent Events

Subsequent Events	9 Months Ended
	Jun. 30, 2016
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10. SUBSEQUENT EVENTS See Note 5 regarding subsequent conversions. Resignation and Appointment of Chief Executive Officer On June 20, 2016, Justin Braune submitted his resignation as Chief Executive Officer and a member of our Board of Directors. Mr. Braune’s resignation was voluntary and not at the request of the Company’s Board of Directors. Ben Beaulieu was appointed Chief Executive Officer. Securities Purchase Agreement with Typenex Co-Investment, LLC On November 1, 2016, the Company closed a Securities Purchase Agreement (the “Typenex Agreement”) with Typenex. Pursuant to the Typenex Agreement, Typenex purchased a Convertible Promissory Note from the Company in the original principal amount of up to $1,413,000 (the “Typenex Note”), at an interest rate of ten percent (10%) per annum. The Typenex Note is unsecured. The principal amount of the Typenex Note included an original issue discount of $128,000 and a transaction fee of $5,000. The investment from Typenex is scheduled to occur in a series of sixteen (16) tranches, represented each by a separate Secured Investor Promissory Note (the “Tranche Notes”) in varying amounts. The first Tranche Note of $40,000 is memorialized in Secured Promissory Note #1, the funding of which occurred on or immediately after the execution of the Typenex Agreement. Each Tranche Note, or any part of it, is convertible into fully paid and non-assessable $0.00001 par value common stock of the Company. The Conversion Price is as described in the Typenex Agreement and is based on at least a 45% discount to the trading price of the Company’s common stock. As a part of the Typenex Agreement, the Company agreed to use its best efforts to cause its authorized but unissued stock to be increased in order for the Company to create a reserve sufficient to meet its conversion obligations under the Typenex Note. The Company is in the process of taking steps in order to increase its authorized but unissued stock to meet its obligations. There is no guarantee that Typenex will fund the remainder of the Typenex Note and in fact it is within Typenex’s sole and absolute discretion whether it ultimately funds Tranche Notes #2- #12. However, in order to secure Typenex’s performance of its obligations under the Typenex Note, as well as any subsequent Tranche Notes, Typenex agreed to pledge a 40% membership interest in Typenex Medical, LLC, an Illinois limited liability company. Should Typenex decide it won’t fund the remainder of the Tranche Notes, the Company’s operating results will suffer and its ability to remain a going concern will be jeopardized. Securities Purchase Agreement with GHS Investments, LLC On October 28, 2016, the Company closed a Securities Purchase Agreement (the “GHS Purchase Agreement”) with GHS. Pursuant to the GHS Purchase Agreement, GHS agreed to purchase and the Company agreed to sell up to $1,105,000 of convertible securities, in the form of a Convertible Promissory Note (the “GHS Note”), at an interest rate of ten percent (10%) per annum. The GHS Note is also attached as Exhibit 10.6 to the 12/27/16 Form 8K and is incorporated herein by this reference. The GHS Note included a ten percent (10%) original issuance discount (i.e., $100,000) and a $5,000 initial transaction fee, as defined in the GHS Purchase Agreement. Upon the closing of the GHS Purchase Agreement, GHS funded $40,000 to the Company (the “Initial Tranche”). Within 15 days of certain conditions being met, an additional $40,000 shall be disbursed by GHS to the Company, in its sole discretion (“Second Tranche”). Within 30 days from the Second Tranche’s issuance, so long as there are no defaults under the GHS Note, GHS in its discretion may fund an additional $50,000 to the Company every 30 days (“Subsequent Tranches”) until $1,000,000 has been funded to the Company. The principal sum and corresponding interest due to GHS shall be prorated based on the consideration actually paid by GHS to the Company in accordance with the GHS Purchase Agreement. Each GHS Note, or any part of it, is convertible into fully paid and non-assessable $0.00001 par value common stock of the Company. The Conversion Price is as described in the GHS Purchase Agreement and is based on at least a 45% discount to the trading price of the Company’s common stock. As a part of the GHS Purchase Agreement, the Company agreed to use its best efforts to cause its authorized but unissued stock to be increased in order for the Company to create a reserve sufficient to meet its conversion obligations. There is no guarantee that GHS will fund the remainder of the Subsequent Tranches and in fact it is within GHS’s sole and absolute discretion whether it ultimately funds the Subsequent Tranches. Should GHS decide it won’t fund the Subsequent Tranches, the Company’s operating results will suffer and its ability to remain a going concern will be jeopardized. Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. On December 10, 2015, the Company entered into a Secured Series B Preferred Stock Convertible Promissory Note in the principal amount of $50,000 (“Series B Note”) with HIVE Ceramics, LLC (the “Holder”). The Series B Note carried an interest rate of 8.0%. The Series B Note was due and payable by the Company on December 10, 2016 (the “Maturity Date”). The Series B Note was convertible into shares of the Company’s Series B Preferred Stock at the option of Holder. The indebtedness represented by the Series B Note was secured by all the Company’s assets. Also on December 10, 2015, the Company entered into an Amended and Restated Secured Series B Preferred Stock Convertible Promissory Note in the principal amount of $250,000 (“Amended Note”) with the Holder. The Amended Note amended, restated, modified and superseded that $250,000 Promissory Note, dated March 27, 2014, entered into by and between the Company and Holder, which note had a principal of $250,000 and a maturity date of February 27, 2016. The Amended Note carried an interest rate of 8.0%. The Amended Note was due and payable by the Company on December 10, 2016 (the “Maturity Date”). The Amended Note was convertible into shares of the Company’s Series B Preferred Stock at the option of Holder. The indebtedness represented by the Amended Note was secured by all the Company’s assets. The Company failed to pay the Series B Note and the Amended Note on the Maturity Date (December 10, 2016). On December 15, 2016, the Company received a Notice of Default from counsel for Holder. Holder’s counsel demanded that all amounts owed under the Series B Note and the Amended Note be paid no later than December 20, 2016. The Company was unable to pay the demanded amounts by December 20, 2016. The Company believes that the Holder intends to execute on the security for the Series B Note and the Amended Note, namely, all of the assets of the Company. The Company is attempting to negotiate a resolution that does not include seizure of the Company’s assets however there is no guarantee that the Company will be able to work out a satisfactory resolution that does not include seizure of the Company’s assets.

Accounting Policies and Basis18

Accounting Policies and Basis of Presentation (Policies)	9 Months Ended
	Jun. 30, 2016
Accounting Policies and Basis of Presentation [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The accompanying unaudited interim consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the SEC. Certain information and disclosures normally included in the annual financial statements prepared in accordance with the accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these consolidated financial statements have been included. Such adjustments consist of normal recurring adjustments. The current results are not an indication of the full year.
CONSOLIDATION	CONSOLIDATION The consolidated financial statements include the assets, liabilities, and operating results of the Company and its wholly-owned subsidiaries, Revival and Nouveau after elimination of all material inter-company accounts and transactions.
USE OF ESTIMATES	USE OF ESTIMATES The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include losses for warrant contingencies and the valuation of conversion features in notes.
FAIR VALUE OF FINANCIAL INSTRUMENTS	FAIR VALUE OF FINANCIAL INSTRUMENTS Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants as of the measurement date. Applicable accounting guidance provides an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors that market participants would use in valuing the asset or liability. There are three levels of inputs that may be used to measure fair value: Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 - Include other inputs that are directly or indirectly observable in the marketplace. Level 3 - Unobservable inputs which are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Derivative instruments include the convertible notes payable warrant liability (Level 2). Derivative instruments are valued using standard calculations/models that are primarily based on observable inputs, including volatilities and interest rates. Therefore, derivative instruments are included in Level 2. Fair-value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2016 and September 30, 2015. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, prepaid expenses, accounts payable, accrued liabilities, and notes payable. Fair values for these items were assumed to approximate carrying values because of their short-term nature or they are payable on demand. The following table presents the Company’s fair value hierarchy for assets measured at fair value on a recurring basis at June 30, 2016: Level 1 Level 2 Level 3 Total Assets Cash and cash equivalents $ 5,410 $ - $ - $ 5,410 Total assets measured at fair value $ 5,410 $ - $ - $ 5,410 Liabilities Derivative instruments $ - $ 724,729 $ - $ 724,729 Total liabilities measured at fair value $ - $ 724,729 $ - $ 724,729 The following table presents the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at September 30, 2015: Level 1 Level 2 Level 3 Total Assets Cash and cash equivalents $ 273,904 $ - $ - $ 273,904 Total assets measured at fair value $ 273,904 $ - $ - $ 273,904 Liabilities Derivative instruments $ - $ 1,672,726 $ - $ 1,672,726 Total liabilities measured at fair value $ - $ 1,672,726 $ - $ 1,672,726
CONCENTRATION	CONCENTRATION Credit Risk At times, the Company maintains cash balances at a financial institution in excess of the FDIC insurance limit. In addition, at we extend credit to customers in the normal course of business, after we evaluate the credit worthiness. The Company does not expect to take any unnecessary credit risks causing significant write-offs of potentially uncollectible accounts. Customers Two (2) customers accounted for 60% of our accounts receivable as of June 30, 2016. One (1) customer accounted for 37% of our accounts receivable as of September 30, 2015. The loss of these customers would have a significant impact on the Company’s financial results. Suppliers Two (2) suppliers accounted for 100% and 98% of our purchases during the three and nine months ended June 30, 2016. Two (2) suppliers 68% and 70% of our purchases during the three and nine months ended June 30, 2015. The loss of these suppliers would have a significant impact on the Company’s financial results.
REVENUE RECOGNITION	REVENUE RECOGNITION The Company recognizes revenues from product sales when (a) persuasive evidence that an agreement exists; (b) the products have been delivered; (c) the prices are fixed and determinable and not subject to refund or adjustment; and (d) collection of the amounts due is reasonably assured. Revenue is generally recorded when sales orders are shipped.
INVENTORY	INVENTORY Inventory is valued at the lower of cost or market, as determined primarily by the average cost inventory method, and are stated using the first-in, first-out (FIFO) method. Management will record a provision for loss for obsolete or slow moving inventory to reduce carrying amounts to net realizable value. We purchase product sourced from China which we are required to pay 50% upon placing the order. Amounts paid for products, which have not been received, are recorded as prepaid inventory. There are no amounts paid which are in dispute or considered impaired.
FIXED ASSETS	FIXED ASSETS Fixed assets are recorded at cost and depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The estimated life of tooling related to our ceramic products is two (2) years. The estimated life of our leasehold improvements is the lesser of the term of the related lease and useful life of the asset.
IMPAIRMENT OF LONG-LIVED AND PURCHASED INTANGIBLE ASSETS	IMPAIRMENT OF LONG-LIVED AND PURCHASED INTANGIBLE ASSETS The Company has adopted Accounting Standards Codification (“ASC”) 350 “Intangibles - Goodwill and Other.” The Statement requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undercounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 350 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell. Long-lived assets, such as fixed assets and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the asset is measured by comparison of its carrying amount to undiscounted future net cash flows the asset is expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the asset exceeds its fair market value. Estimates of expected future cash flows represent management’s best estimate based on currently available information and reasonable and supportable assumptions. Any impairment recognized is permanent and may not be restored. During the three and nine months ended June 30, 2016 and 2015, the Company did not record any impairment of its trademarks as its expected future cash flows are in excess of their carrying amounts.
RESEARCH AND DEVELOPMENT	RESEARCH AND DEVELOPMENT Research and development costs are expensed as incurred. The costs of materials and equipment that will be acquired or constructed for research and development activities, and that have alternative future uses, both in research and development, marketing or sales, will be classified as fixed assets and depreciated over their estimated useful lives. To date, research and development costs include the research and development expenses related to prototypes of the Company’s products. During the three and nine months ended June 30, 2016 and 2015, research and development costs were $950 and $91,428, and $47,648 and $143,481, respectively.
CONVERTIBLE DEBT	CONVERTIBLE DEBT Convertible debt is accounted for under the guidelines established by ASC 470-20 “Debt with Conversion and Other Options.” ASC 470-20 governs the calculation of an embedded beneficial conversion, which is treated as an additional discount to the instruments where derivative accounting (explained below) does not apply. The amount of the value of warrants and beneficial conversion feature may reduce the carrying value of the instrument to zero, but no further. Many of the conversion features embedded in the Company’s notes are variable and are adjusted based on a discount to market prices which could cause an unlimited number of common stock to be issued. In these cases, we record the embedded conversion feature as a derivate instrument, at fair value. The embedded conversion features are recorded as discounts when the notes become convertible. The excess of fair value of the embedded conversion feature over the carrying value of the debt is recorded as an immediate charge to operations. Each reporting period, the Company will compute the estimated fair value of derivatives and record changes to operations. The discounts relating to the initial recording of the derivatives or beneficial conversion features are accreted over the term of the debt using the effective interest method. Notes with cash payment penalties are recorded over the six month term of the note. The Company has lost the ability to increase the share reserves due to the significantly increased outstanding held by convertible noteholders and a shareholder vote is required to increase the authorized amount of shares the Company may issue. Further, the combination of limited capital and depleted share reserves have severely damaged the Company’s ability to find continued finance, properly run the Company, and proceed with business to include any mergers or acquisitions or any transactions that would require available stock.
DERIVATIVE FINANCIAL INSTRUMENTS	DERIVATIVE FINANCIAL INSTRUMENTS Derivative financial instruments, as defined in ASC 815, “Accounting for Derivative Financial Instruments and Hedging Activities”, consist of financial instruments or other contracts that contain a notional amount and one or more underlying (e.g. interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets. The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company has issued financial instruments including senior convertible notes payable and freestanding stock purchase warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by ASC 815, in certain instances, these instruments are required to be carried as derivative liabilities, at fair value, in our consolidated financial statements. The Company estimates the fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered to be consistent with objectively measuring fair values. In selecting the appropriate technique, consideration is given to, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex derivative instruments, such as free-standing warrants, the Company generally uses the Black-Scholes option valuation technique because it embodies all of the requisite assumptions (including trading volatility, estimated terms and risk free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock, which has a high-historical volatility. Since derivative financial instruments are initially and subsequently carried at fair values, the Company’s operating results will reflect the volatility in these estimate and assumption changes.
EARNINGS (LOSS) PER COMMON SHARE	EARNINGS (LOSS) PER COMMON SHARE Basic earnings (loss) per common share is computed by dividing net income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing net income available to common shareholders by the combination of dilutive common share equivalents, comprised of shares issuable under the Company’s share-based compensation plans and the weighted-average number of common shares outstanding during the reporting period. Dilutive common share equivalents include the dilutive effect of in-the-money share equivalents, which are calculated, based on the average share price for each period using the treasury stock method. Under the treasury stock method, the exercise price of an award, if any, the amount of compensation cost, if any, for future service that the Company has not yet recognized, and the estimated tax benefits that would be recorded in paid-in capital, if any, when an award is settled are assumed to be used to repurchase shares in the current period. In the event of losses, such common share equivalents are excluded as their effects are antidilutive. The following is a summary of outstanding securities which have been included in the calculation of diluted net income per share and reconciliation of net income to net income available to common stock holders for the three months ended June 30, 2016: For the June 30, Weighted average common shares outstanding used in calculating basic earnings per share 215,717,808 Effect of preferred stock 500,000 Effect of convertible notes payable 881,166,280 Weighted average common and common equivalent shares used in calculating diluted earnings per share 1,097,384,088 Net income as reported $ 1,434,703 Add - interest on convertible notes payable 408,419 Net income available to common stockholders $ 1,843,122 The following is a summary of outstanding securities that would have been included in the calculation of diluted shares outstanding since the exercise prices did not exceed the average market value of the Company’s common stock if the Company generated net income for the nine months ended June 30, 2016: For the June 30, 2016 Series A Preferred stock 500,000 Convertible notes 881,166,280 881,666,280 The Company excluded 110,000 options from the computation for the nine months ended June 30, 2015, as their exercise prices were in excess of the average closing market price of the Company’s common stock, causing their effects to be anti-dilutive using the treasury stock method. During the three months ended June 30, 2015, no options would have been included had the Company generated net income in the computation of dilutive shares outstanding using the treasury-stock method since the exercise prices exceeded the average market value of the Company’s common stock. The following is a summary of outstanding securities which have been included in the calculation of diluted net income per share and reconciliation of net income to net income available to common stock holders for the nine months ended June 30, 2015: For the June 30, Weighted average common shares outstanding used in calculating basic earnings per share 11,253,868 Effect of preferred stock 500,000 Effect of convertible notes payable 1,924,046 Effect of options and warrants 197,012 Weighted average common and common equivalent shares used in calculating diluted earnings per share 13,874,926 Net income as reported $ 232,002 Add - interest on convertible notes payable 427,240 Net income available to common stockholders $ 659,242
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION ASC 718, “Share-Based Payment” requires that compensation cost related to share-based payment transactions be recognized in the consolidated financial statements. Share-based payment transactions within the scope of ASC 718 include stock options, restricted stock plans, performance-based awards, stock appreciation rights, and employee share purchase plans. The Company adopted ASC 718, which requires disclosure of the fair value and other characteristics of stock options and more prominent disclosure about the effects of an entity’s accounting policy decisions with respect to stock-based compensation on reported net loss. The Company has reflected the expense of such stock based compensation based on the fair value at the grant date for awards consistent with the provisions of ASC 718. In connection with the adoption of ASC 718, the fair value of our share-based compensation has been determined utilizing the Black-Scholes pricing model. The fair value of the options granted is amortized as compensation expense on a straight line basis over the requisite service period of the award, which is generally the vesting period. The fair value calculations involve significant judgments, assumptions, estimates and complexities that impact the amount of compensation expense to be recorded in current and future periods. Upon option exercise, the Company issues new shares of stock. The following weighted average variables were used in the Black Scholes model for all option issuances valued during the nine months ended June 30, 2016 and 2015: Nine Months Stock Price at Dividend Exercise Risk Free Volatility Average 2016 n/a n/a n/a n/a n/a n/a 2015 $ 0.73 n/a $ 0.73 2.2 % 380 % 10.0 The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of Emerging Issues Task Force (“EITF”) 96-18, “Accounting for Equity Instruments That are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services”, codified into ASC 505-50. The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement. Prepaid stock-based compensation is recorded when shares are issued based on the value on the grant date, but vest over the contractual period at which time the prorated expense will be recorded.
RECENT ACCOUNTING PRONOUNCEMENTS	RECENT ACCOUNTING PRONOUNCEMENTS In April 2015, the FASB issued Accounting Standard Update (“ASU”) 2015-03 Simplifying the Presentation of Debt Issuance Costs. This update requires capitalized debt issuance costs to be classified as a reduction to the carrying value of debt rather than a deferred charge, as is currently required. This update will be effective for the Company for all annual and interim periods beginning after December 15, 2015 and is required to be adopted retroactively for all periods presented, and early adoption is permitted. The Company adopted the policy during the quarter ending March 31, 2016. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers”, which supersedes most of the current revenue recognition requirements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for these goods or services. New disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers are also required. This guidance is effective for the Company in the first quarter of fiscal year 2018 and early application is not permitted. Entities must adopt the new guidance using one of two retrospective application methods. The Company is currently evaluating the standard but does not expect it to have a material impact on our financial position, results of operations or cash flows. In August 2014, the FASB issued ASU 2014-15, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued.2 An entity must provide certain disclosures if “conditions or events raise substantial doubt about the entity’s ability to continue as a going concern.” The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Financial Accounting Standards Board issues Accounting Standard Updates (“ASUs”) to amend the authoritative literature in Accounting Standards Codification (“ASC”). There have been a number of ASUs to date that amend the original text of ASC. The Company believes those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.
RISKS AND UNCERTAINTIES	RISKS AND UNCERTAINTIES Although forward-looking statements in this Quarterly Report reflect our good faith judgment, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include without limitation those discussed under the heading “Risk Factors” below, as well as those discussed elsewhere in this Quarterly Report. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report. Readers are urged to carefully review and consider the various disclosures made in this Quarterly Report, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

Accounting Policies and Basis19

Accounting Policies and Basis of Presentation (Tables)	9 Months Ended
	Jun. 30, 2016
Accounting Policies and Basis of Presentation [Abstract]
Schedule of assets and liabilities measured at fair value on a recurring basis	Level 1 Level 2 Level 3 Total Assets Cash and cash equivalents $ 5,410 $ - $ - $ 5,410 Total assets measured at fair value $ 5,410 $ - $ - $ 5,410 Liabilities Derivative instruments $ - $ 724,729 $ - $ 724,729 Total liabilities measured at fair value $ - $ 724,729 $ - $ 724,729 Level 1 Level 2 Level 3 Total Assets Cash and cash equivalents $ 273,904 $ - $ - $ 273,904 Total assets measured at fair value $ 273,904 $ - $ - $ 273,904 Liabilities Derivative instruments $ - $ 1,672,726 $ - $ 1,672,726 Total liabilities measured at fair value $ - $ 1,672,726 $ - $ 1,672,726
Schedule of reconcilliation of net income available to common shareholders	For the June 30, Weighted average common shares outstanding used in calculating basic earnings per share 215,717,808 Effect of preferred stock 500,000 Effect of convertible notes payable 881,166,280 Weighted average common and common equivalent shares used in calculating diluted earnings per share 1,097,384,088 Net income as reported $ 1,434,703 Add - interest on convertible notes payable 408,419 Net income available to common stockholders $ 1,843,122 For the June 30, Weighted average common shares outstanding used in calculating basic earnings per share 11,253,868 Effect of preferred stock 500,000 Effect of convertible notes payable 1,924,046 Effect of options and warrants 197,012 Weighted average common and common equivalent shares used in calculating diluted earnings per share 13,874,926 Net income as reported $ 232,002 Add - interest on convertible notes payable 427,240 Net income available to common stockholders $ 659,242
Schedule of securities to be included in diluted share calculation	For the June 30, 2016 Series A Preferred stock 500,000 Convertible notes 881,166,280 881,666,280
Schedule of weighted average variables used in Black Scholes model	Nine Months Stock Price at Dividend Exercise Risk Free Volatility Average 2016 n/a n/a n/a n/a n/a n/a 2015 $ 0.73 n/a $ 0.73 2.2 % 380 % 10.0

Fixed Assets (Tables)

Fixed Assets (Tables)	9 Months Ended
	Jun. 30, 2016
Fixed Assets [Abstract]
Summary of fixed assets	June 30, September 30, Molds and Tooling $ 219,115 $ 176,015 Leasehold improvements 29,795 29,795 Accumulated depreciation (194,449 ) (87,483 ) $ 54,461 $ 118,327

Accrued Expenses (Tables)

Accrued Expenses (Tables)	9 Months Ended
	Jun. 30, 2016
Accrued Expenses [Abstract]
Summary of accrued expenses	June 30, 2016 September 30, Accrued interest $ 139,929 $ 46,337 Accrued interest - related party 38,331 24,538 Accrued wages and taxes 223,224 112,322 Other 3,102 24,412 $ 404,586 $ 207,609

Third Party Debt (Tables)

Third Party Debt (Tables)	9 Months Ended
	Jun. 30, 2016
Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Shedule of conversions for payments	Conversion Date Principal Converted Accrued Interest Converted Total Converted Conversion Rate Common Shares Issued October 8, 2015 $ 21,000 $ - $ 21,000 $ 0.012 1,818,182 October 16, 2015 18,900 - 18,900 $ 0.012 1,636,364 October 22, 2015 25,800 - 25,800 $ 0.011 2,333,786 October 29, 2015 22,460 - 22,460 $ 0.011 2,031,660 November 11, 2015 33,500 - 33,500 $ 0.007 4,649,549 November 18, 2015 24,000 - 24,000 $ 0.006 4,195,804 November 30, 2015 30,000 - 30,000 $ 0.005 5,741,627 December 11, 2015 22,000 - 22,000 $ 0.002 9,090,909 December 28, 2015 22,500 - 22,500 $ 0.002 9,297,521 January 7, 2016 20,000 - 20,000 $ 0.002 10,101,010 January 20, 2016 12,500 - 12,500 $ 0.001 10,330,579 February 2, 2016 13,200 - 13,200 $ 0.001 10,909,091 March 2, 2016 10,627 - 10,627 $ 0.001 10,169,800 March 10, 2016 11,184 - 11,184 $ 0.001 10,702,619 March 17, 2016 8,272 - 8,272 $ 0.001 6,539,200 March 29, 2016 22,797 - 22,797 $ 0.002 12,191,000 March 31, 2016 22,347 - 22,347 $ 0.002 11,950,000 April 4, 2016 25,140 - 25,140 $ 0.002 13,444,000 April 7, 2016 21,019 - 21,019 $ 0.002 11,240,000 April 13, 2016 35,664 - 35,664 $ 0.002 14,737,000 April 19, 2016 36,711 - 36,711 $ 0.002 15,170,000 April 20, 2016 18,244 - 18,244 $ 0.002 7,538,666 $ 477,865 $ - $ 477,865 185,818,367
$2M Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Shedule of conversions for payments	Conversion Date Principal Converted Accrued Interest Converted Total Converted Conversion Rate Common Shares Issued October 1, 2015 $ 10,000 $ - $ 10,000 $ 0.015 675,676 October 5, 2015 10,000 - 10,000 $ 0.015 675,676 October 6, 2015 13,262 - 13,262 $ 0.014 961,000 October 7, 2015 10,000 - 10,000 $ 0.012 865,801 October 9, 2015 11,728 - 11,728 $ 0.012 1,011,000 October 9, 2015 10,000 - 10,000 $ 0.012 865,801 October 12, 2015 14,680 - 14,680 $ 0.012 1,271,000 October 13, 2015 11,601 - 11,601 $ 0.012 1,000,052 October 15, 2015 14,680 - 14,680 $ 0.012 1,271,000 October 19, 2015 17,400 - 17,400 $ 0.012 1,500,000 October 19, 2015 15,000 - 15,000 $ 0.012 1,298,701 October 20, 2015 16,650 - 16,650 $ 0.011 1,500,000 October 21, 2015 17,500 - 17,500 $ 0.012 1,515,152 October 23, 2015 20,000 - 20,000 $ 0.012 1,731,602 October 26, 2015 24,420 - 24,420 $ 0.011 2,200,000 October 29, 2015 26,640 - 26,640 $ 0.011 2,400,000 November 2, 2015 29,970 - 29,970 $ 0.011 2,700,000 November 2, 2015 20,000 - 20,000 $ 0.011 1,809,136 November 5, 2015 32,190 - 32,190 $ 0.011 2,900,000 November 10, 2015 28,800 - 28,800 $ 0.010 3,000,000 November 12, 2015 23,930 - 23,930 $ 0.007 3,323,611 November 17, 2015 16,500 - 16,500 $ 0.006 2,727,273 November 19, 2015 1,640 11,225 12,865 $ 0.006 2,316,013 November 23, 2015 23,111 - 23,111 $ 0.006 4,127,000 November 27, 2015 24,750 - 24,750 $ 0.006 4,500,000 December 2, 2015 18,450 - 18,450 $ 0.004 4,500,000 December 8, 2015 18,000 - 18,000 $ 0.004 5,000,000 December 11, 2015 13,368 - 13,368 $ 0.002 5,570,000 December 16, 2015 14,181 - 14,181 $ 0.002 5,860,000 December 22, 2015 15,488 - 15,488 $ 0.002 6,400,000 December 29, 2015 17,666 17,666 $ 0.002 7,300,000 May 31, 2016 27,495 - 27,495 $ 0.001 19,227,000 June 13, 2016 28,936 - 28,936 $ 0.001 20,235,000 June 21, 2016 22,254 - 22,254 $ 0.001 21,296,000 June 28, 2016 12,339 2,589 14,928 $ 0.001 16,964,625 $ 632,629 $ 13,814 $ 646,443 160,498,119 Conversion Date Principal Converted Accrued Interest Converted Total Converted Conversion Rate Common Shares Issued April 20, 2016 $ 16,117 $ - $ 16,117 $ 0.0024 6,660,000 April 25, 2016 46,349 - 46,349 $ 0.0029 15,900,000 May 5, 2016 37,744 - 37,744 $ 0.0025 15,250,000 May 18, 2016 19,597 1,594 21,191 $ 0.0020 10,413,268 $ 119,807 $ 1,594 $ 121,401 48,223,268 Conversion Date Principal Converted Accrued Interest Converted Total Converted Conversion Rate Common Shares Issued July 8, 2016 $ 19,222 $ - $ 19,222 $ 0.0008 23,300,000 July 25, 2016 17,518 - 17,518 $ 0.0007 24,500,000 August 3, 2016 17,738 - 17,738 $ 0.0007 25,800,000 August 10, 2016 17,919 - 17,919 $ 0.0007 27,150,000 September 19, 2016 11,482 - 11,482 $ 0.0008 14,912,185 January 10, 2017 41,121 879 42,000 $ 0.0014 30,000,000 January 18, 2017 - 28,795 28,795 $ 0.0045 6,398,894 $ 125,000 $ 29,674 $ 154,674 152,061,079

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	9 Months Ended
	Jun. 30, 2016
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of company's warrant activity	Shares Weighted Average Weighted Average Remaining Contractual Term Aggregate Intrinsic Warrants outstanding at September 30, 2015 1,184,726 $ 0.114 0.9 $ 739,812 Warrants issued - - Warrants exercised - - Cancelled/forfeited/expired (1,184,726 ) $ 0.114 - - Warrants outstanding at June 30, 2016 - $ - - $ -

Description of Business and S24

Description of Business and Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Sep. 30, 2015	Sep. 30, 2014
Description of Business and Summary of Significant Accounting Policies (Textual)
Working capital deficit	$ 1,960,283		$ 1,960,283
Cash	5,410	$ 134,059	5,410	$ 134,059	$ 273,904	$ 48,370
Net loss	1,434,703	$ (436,052)	(3,865,758)	$ 232,002
Accumulated deficit	$ (32,032,503)		$ (32,032,503)		$ (28,166,745)

Accounting Policies and Basis25

Accounting Policies and Basis of Presentation (Details) - Fair Value, Measurements, Recurring [Member] - USD ($)	Jun. 30, 2016	Sep. 30, 2015
Assets
Cash and cash equivalents	$ 5,410	$ 273,904
Total assets measured at fair value	5,410	273,904
Liabilities
Derivative instruments	724,729	1,672,726
Total liabilities measured at fair value	724,729	1,672,726
Level 1 [Member]
Assets
Cash and cash equivalents	5,410	273,904
Total assets measured at fair value	5,410	273,904
Liabilities
Derivative instruments
Total liabilities measured at fair value
Level 2 [Member]
Assets
Cash and cash equivalents
Total assets measured at fair value
Liabilities
Derivative instruments	724,729	1,672,726
Total liabilities measured at fair value	724,729	1,672,726
Level 3 [Member]
Assets
Cash and cash equivalents
Total assets measured at fair value
Liabilities
Derivative instruments
Total liabilities measured at fair value

Accounting Policies and Basis26

Accounting Policies and Basis of Presentation (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Accounting Policies and Basis of Presentation [Abstract]
Weighted average common shares outstanding used in calculating basic earnings per share	215,717,808			11,253,868
Effect of preferred stock	500,000			500,000
Effect of convertible notes payable	881,166,280			1,924,046
Effect of options and warrants				197,012
Weighted average common and common equivalent shares used in calculating diluted earnings per share	1,097,384,088	11,925,400	220,677,405	13,874,926
Net income as reported	$ 1,434,703	$ (436,052)	$ (3,865,758)	$ 232,002
Add - interest on convertible notes payable	408,419			427,240
Net income available to common stockholders	$ 1,843,122			$ 659,242

Accounting Policies and Basis27

Accounting Policies and Basis of Presentation (Details 2)	9 Months Ended
	Jun. 30, 2016shares
Diluted shares outstanding	881,666,280
Series A Preferred stock [Member]
Diluted shares outstanding	500,000
Convertible notes [Member]
Diluted shares outstanding	881,166,280

Accounting Policies and Basis28

Accounting Policies and Basis of Presentation (Details 3) - $ / shares	9 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Weighted average variables used in the Black Scholes model
Stock Price at Grant Date		$ 0.73
Dividend Yield
Exercise Price		$ 0.73
Risk Free Interest Rate		2.20%
Volatility		380.00%
Average Life		10 years

Accounting Policies and Basis29

Accounting Policies and Basis of Presentation (Details Textual)	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2016USD ($)suppliers	Jun. 30, 2015USD ($)suppliers	Jun. 30, 2016USD ($)customersuppliers	Jun. 30, 2015USD ($)suppliersshares	Sep. 30, 2015customer
Accounting policies and basis of presentation (Textual)
Inventory, Description			We purchase product sourced from China which we are required to pay 50% upon placing the order.
Research and development costs | $	$ 950	$ 91,428	$ 47,648	$ 143,481
Number of options excluded from the compution of diluted shares outstanding | shares				110,000
Customers [Member]
Accounting policies and basis of presentation (Textual)
Number of customers | customer			2		1
Credit risk rate			60.00%		37.00%
Suppliers [Member]
Accounting policies and basis of presentation (Textual)
Number of suppliers | suppliers	2	2	2	2
Credit risk rate	100.00%	68.00%	98.00%	70.00%

Fixed Assets (Details)

Fixed Assets (Details) - USD ($)	Jun. 30, 2016	Sep. 30, 2015
Fixed Assets [Abstract]
Molds and Tooling	$ 219,115	$ 176,015
Leasehold improvements	29,795	29,795
Accumulated depreciation	(194,449)	(87,483)
Fixed assets, net	$ 54,461	$ 118,327

Fixed Assets (Details Textual)

Fixed Assets (Details Textual) - USD ($)	9 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Fixed Assets [Abstract]
Depreciation expense	$ 106,967	$ 49,990

Accrued Expenses (Details)

Accrued Expenses (Details) - USD ($)	Jun. 30, 2016	Sep. 30, 2015
Accrued Expenses [Abstract]
Accrued interest	$ 139,929	$ 46,337
Accrued interest - related party	38,331	24,538
Accrued wages and taxes	223,224	112,322
Other	3,102	24,412
Accrued expenses	$ 404,586	$ 207,609

Accrued Expenses (Details Textu

Accrued Expenses (Details Textual)	Jun. 30, 2016USD ($)
Kyle Tracey [Member]
Accrued Expenses (Textual)
Accrued wages	$ 25,000
Joe Andreae [Member]
Accrued Expenses (Textual)
Accrued wages	16,667
Mike Cook [Member]
Accrued Expenses (Textual)
Accrued wages	43,742
Allan Viernes [Member]
Accrued Expenses (Textual)
Accrued wages	36,382
Benjamin Beaulieu [Member]
Accrued Expenses (Textual)
Accrued wages	38,048
Justin Brauneare [Member]
Accrued Expenses (Textual)
Accrued wages	$ 25,792

Third Party Debt (Details)

Third Party Debt (Details) - USD ($)	9 Months Ended
	Jun. 30, 2016	Aug. 13, 2015	Dec. 03, 2014
Debt Instrument [Line Items]
Principal Converted		$ 800,000
Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Principal Converted	$ 477,865		$ 500,000
Accrued Interest Converted
Total Converted	$ 477,865
Common Shares Issued	185,818,367
Securities Purchase Agreement [Member] | October 8, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 21,000
Accrued Interest Converted
Total Converted	$ 21,000
Conversion Rate	$ 0.012
Common Shares Issued	1,818,182
Securities Purchase Agreement [Member] | October 16, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 18,900
Accrued Interest Converted
Total Converted	$ 18,900
Conversion Rate	$ 0.012
Common Shares Issued	1,636,364
Securities Purchase Agreement [Member] | October 22, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 25,800
Accrued Interest Converted
Total Converted	$ 25,800
Conversion Rate	$ 0.011
Common Shares Issued	2,333,786
Securities Purchase Agreement [Member] | October 29, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 22,460
Accrued Interest Converted
Total Converted	$ 22,460
Conversion Rate	$ 0.011
Common Shares Issued	2,031,660
Securities Purchase Agreement [Member] | November 11, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 33,500
Accrued Interest Converted
Total Converted	$ 33,500
Conversion Rate	$ 0.007
Common Shares Issued	4,649,549
Securities Purchase Agreement [Member] | November 18, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 24,000
Accrued Interest Converted
Total Converted	$ 24,000
Conversion Rate	$ 0.006
Common Shares Issued	4,195,804
Securities Purchase Agreement [Member] | November 30, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 30,000
Accrued Interest Converted
Total Converted	$ 30,000
Conversion Rate	$ 0.005
Common Shares Issued	5,741,627
Securities Purchase Agreement [Member] | December 11, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 22,000
Accrued Interest Converted
Total Converted	$ 22,000
Conversion Rate	$ 0.002
Common Shares Issued	9,090,909
Securities Purchase Agreement [Member] | December 28, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 22,500
Accrued Interest Converted
Total Converted	$ 22,500
Conversion Rate	$ 0.002
Common Shares Issued	9,297,521
Securities Purchase Agreement [Member] | January 7, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 20,000
Accrued Interest Converted
Total Converted	$ 20,000
Conversion Rate	$ 0.002
Common Shares Issued	10,101,010
Securities Purchase Agreement [Member] | January 20, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 12,500
Accrued Interest Converted
Total Converted	$ 12,500
Conversion Rate	$ 0.001
Common Shares Issued	10,330,579
Securities Purchase Agreement [Member] | February 2, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 13,200
Accrued Interest Converted
Total Converted	$ 13,200
Conversion Rate	$ 0.001
Common Shares Issued	10,909,091
Securities Purchase Agreement [Member] | March 2, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 10,627
Accrued Interest Converted
Total Converted	$ 10,627
Conversion Rate	$ 0.001
Common Shares Issued	10,169,800
Securities Purchase Agreement [Member] | March 10, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 11,184
Accrued Interest Converted
Total Converted	$ 11,184
Conversion Rate	$ 0.001
Common Shares Issued	10,702,619
Securities Purchase Agreement [Member] | March 17, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 8,272
Accrued Interest Converted
Total Converted	$ 8,272
Conversion Rate	$ 0.001
Common Shares Issued	6,539,200
Securities Purchase Agreement [Member] | March 29, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 22,797
Accrued Interest Converted
Total Converted	$ 22,797
Conversion Rate	$ 0.002
Common Shares Issued	12,191,000
Securities Purchase Agreement [Member] | March 31, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 22,347
Accrued Interest Converted
Total Converted	$ 22,347
Conversion Rate	$ 0.002
Common Shares Issued	11,950,000
Securities Purchase Agreement [Member] | April 4, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 25,140
Accrued Interest Converted
Total Converted	$ 25,140
Conversion Rate	$ 0.002
Common Shares Issued	13,444,000
Securities Purchase Agreement [Member] | April 7, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 21,019
Accrued Interest Converted
Total Converted	$ 21,019
Conversion Rate	$ 0.002
Common Shares Issued	11,240,000
Securities Purchase Agreement [Member] | April 13, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 35,664
Accrued Interest Converted
Total Converted	$ 35,664
Conversion Rate	$ 0.002
Common Shares Issued	14,737,000
Securities Purchase Agreement [Member] | April 19, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 36,711
Accrued Interest Converted
Total Converted	$ 36,711
Conversion Rate	$ 0.002
Common Shares Issued	15,170,000
Securities Purchase Agreement [Member] | April 20, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 18,244
Accrued Interest Converted
Total Converted	$ 18,244
Conversion Rate	$ 0.002
Common Shares Issued	7,538,666

Third Party Debt (Details 1)

Third Party Debt (Details 1) - USD ($)	9 Months Ended
	Jun. 30, 2016	Aug. 13, 2015
Debt Instrument [Line Items]
Principal Converted		$ 800,000
$2M Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Principal Converted	$ 632,629	$ 2,000,000
Accrued Interest Converted	13,814
Total Converted	$ 646,443
Common Shares Issued	160,498,119
$2M Securities Purchase Agreement [Member] | October 1, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 10,000
Accrued Interest Converted
Total Converted	$ 10,000
Conversion Rate	$ 0.015
Common Shares Issued	675,676
$2M Securities Purchase Agreement [Member] | October 5, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 10,000
Accrued Interest Converted
Total Converted	$ 10,000
Conversion Rate	$ 0.015
Common Shares Issued	675,676
$2M Securities Purchase Agreement [Member] | October 6, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 13,262
Accrued Interest Converted
Total Converted	$ 13,262
Conversion Rate	$ 0.014
Common Shares Issued	961,000
$2M Securities Purchase Agreement [Member] | October 7, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 10,000
Accrued Interest Converted
Total Converted	$ 10,000
Conversion Rate	$ 0.012
Common Shares Issued	865,801
$2M Securities Purchase Agreement [Member] | October 9, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 11,728
Accrued Interest Converted
Total Converted	$ 11,728
Conversion Rate	$ 0.012
Common Shares Issued	1,011,000
$2M Securities Purchase Agreement [Member] | October 9, 2015 One [Member]
Debt Instrument [Line Items]
Principal Converted	$ 10,000
Accrued Interest Converted
Total Converted	$ 10,000
Conversion Rate	$ 0.012
Common Shares Issued	865,801
$2M Securities Purchase Agreement [Member] | October 12, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 14,680
Accrued Interest Converted
Total Converted	$ 14,680
Conversion Rate	$ 0.012
Common Shares Issued	1,271,000
$2M Securities Purchase Agreement [Member] | October 13, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 11,601
Accrued Interest Converted
Total Converted	$ 11,601
Conversion Rate	$ 0.012
Common Shares Issued	1,000,052
$2M Securities Purchase Agreement [Member] | October 15, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 14,680
Accrued Interest Converted
Total Converted	$ 14,680
Conversion Rate	$ 0.012
Common Shares Issued	1,271,000
$2M Securities Purchase Agreement [Member] | October 19, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 17,400
Accrued Interest Converted
Total Converted	$ 17,400
Conversion Rate	$ 0.012
Common Shares Issued	1,500,000
$2M Securities Purchase Agreement [Member] | October 19, 2015 One [Member]
Debt Instrument [Line Items]
Principal Converted	$ 15,000
Accrued Interest Converted
Total Converted	$ 15,000
Conversion Rate	$ 0.012
Common Shares Issued	1,298,701
$2M Securities Purchase Agreement [Member] | October 20, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 16,650
Accrued Interest Converted
Total Converted	$ 16,650
Conversion Rate	$ 0.011
Common Shares Issued	1,500,000
$2M Securities Purchase Agreement [Member] | October 21, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 17,500
Accrued Interest Converted
Total Converted	$ 17,500
Conversion Rate	$ 0.012
Common Shares Issued	1,515,152
$2M Securities Purchase Agreement [Member] | October 23, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 20,000
Accrued Interest Converted
Total Converted	$ 20,000
Conversion Rate	$ 0.012
Common Shares Issued	1,731,602
$2M Securities Purchase Agreement [Member] | October 26, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 24,420
Accrued Interest Converted
Total Converted	$ 24,420
Conversion Rate	$ 0.011
Common Shares Issued	2,200,000
$2M Securities Purchase Agreement [Member] | October 29, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 26,640
Accrued Interest Converted
Total Converted	$ 26,640
Conversion Rate	$ 0.011
Common Shares Issued	2,400,000
$2M Securities Purchase Agreement [Member] | November 2, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 29,970
Accrued Interest Converted
Total Converted	$ 29,970
Conversion Rate	$ 0.011
Common Shares Issued	2,700,000
$2M Securities Purchase Agreement [Member] | November 2, 2015 One [Member]
Debt Instrument [Line Items]
Principal Converted	$ 20,000
Accrued Interest Converted
Total Converted	$ 20,000
Conversion Rate	$ 0.011
Common Shares Issued	1,809,136
$2M Securities Purchase Agreement [Member] | November 5, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 32,190
Accrued Interest Converted
Total Converted	$ 32,190
Conversion Rate	$ 0.011
Common Shares Issued	2,900,000
$2M Securities Purchase Agreement [Member] | November 10, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 28,800
Accrued Interest Converted
Total Converted	$ 28,800
Conversion Rate	$ 0.010
Common Shares Issued	3,000,000
$2M Securities Purchase Agreement [Member] | November 12, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 23,930
Accrued Interest Converted
Total Converted	$ 23,930
Conversion Rate	$ 0.007
Common Shares Issued	3,323,611
$2M Securities Purchase Agreement [Member] | November 17, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 16,500
Accrued Interest Converted
Total Converted	$ 16,500
Conversion Rate	$ 0.006
Common Shares Issued	2,727,273
$2M Securities Purchase Agreement [Member] | November 19, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 1,640
Accrued Interest Converted	11,225
Total Converted	$ 12,865
Conversion Rate	$ 0.006
Common Shares Issued	2,316,013
$2M Securities Purchase Agreement [Member] | November 23, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 23,111
Accrued Interest Converted
Total Converted	$ 23,111
Conversion Rate	$ 0.006
Common Shares Issued	4,127,000
$2M Securities Purchase Agreement [Member] | November 27, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 24,750
Accrued Interest Converted
Total Converted	$ 24,750
Conversion Rate	$ 0.006
Common Shares Issued	4,500,000
$2M Securities Purchase Agreement [Member] | December 2, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 18,450
Accrued Interest Converted
Total Converted	$ 18,450
Conversion Rate	$ 0.004
Common Shares Issued	4,500,000
$2M Securities Purchase Agreement [Member] | December 8, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 18,000
Accrued Interest Converted
Total Converted	$ 18,000
Conversion Rate	$ 0.004
Common Shares Issued	5,000,000
$2M Securities Purchase Agreement [Member] | December 11, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 13,368
Accrued Interest Converted
Total Converted	$ 13,368
Conversion Rate	$ 0.002
Common Shares Issued	5,570,000
$2M Securities Purchase Agreement [Member] | December 16, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 14,181
Accrued Interest Converted
Total Converted	$ 14,181
Conversion Rate	$ 0.002
Common Shares Issued	5,860,000
$2M Securities Purchase Agreement [Member] | December 22, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 15,488
Accrued Interest Converted
Total Converted	$ 15,488
Conversion Rate	$ 0.002
Common Shares Issued	6,400,000
$2M Securities Purchase Agreement [Member] | December 29, 2015 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 17,666
Accrued Interest Converted
Total Converted	$ 17,666
Conversion Rate	$ 0.002
Common Shares Issued	7,300,000
$2M Securities Purchase Agreement [Member] | May 31, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 27,495
Accrued Interest Converted
Total Converted	$ 27,495
Conversion Rate	$ 0.001
Common Shares Issued	19,227,000
$2M Securities Purchase Agreement [Member] | June 13, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 28,936
Accrued Interest Converted
Total Converted	$ 28,936
Conversion Rate	$ 0.001
Common Shares Issued	20,235,000
$2M Securities Purchase Agreement [Member] | June 21, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 22,254
Accrued Interest Converted
Total Converted	$ 22,254
Conversion Rate	$ 0.001
Common Shares Issued	21,296,000
$2M Securities Purchase Agreement [Member] | June 28, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 12,339
Accrued Interest Converted	2,589
Total Converted	$ 14,928
Conversion Rate	$ 0.001
Common Shares Issued	16,964,625

Third Party Debt (Details 2)

Third Party Debt (Details 2) - USD ($)	9 Months Ended
	Jun. 30, 2016	Aug. 13, 2015
Debt Instrument [Line Items]
Principal Converted		$ 800,000
$2M Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Principal Converted	$ 119,807
Accrued Interest Converted	1,594
Total Converted	$ 121,401
Common Shares Issued	48,223,268
$2M Securities Purchase Agreement [Member] | April 20, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 16,117
Accrued Interest Converted
Total Converted	$ 16,117
Conversion Rate	$ 0.0024
Common Shares Issued	6,660,000
$2M Securities Purchase Agreement [Member] | April 25, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 46,349
Accrued Interest Converted
Total Converted	$ 46,349
Conversion Rate	$ 0.0029
Common Shares Issued	15,900,000
$2M Securities Purchase Agreement [Member] | May 5, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 37,744
Accrued Interest Converted
Total Converted	$ 37,744
Conversion Rate	$ 0.0025
Common Shares Issued	15,250,000
$2M Securities Purchase Agreement [Member] | May 18, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 19,597
Accrued Interest Converted	1,594
Total Converted	$ 21,191
Conversion Rate	$ 0.0020
Common Shares Issued	10,413,268

Third Party Debt (Details 3)

Third Party Debt (Details 3) - USD ($)	9 Months Ended
	Jun. 30, 2016	Aug. 13, 2015
Debt Instrument [Line Items]
Principal Converted		$ 800,000
$2M Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Principal Converted	$ 125,000
Accrued Interest Converted	29,674
Total Converted	$ 154,674
Common Shares Issued	152,061,079
$2M Securities Purchase Agreement [Member] | July 8, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 19,222
Accrued Interest Converted
Total Converted	$ 19,222
Conversion Rate	$ 0.0008
Common Shares Issued	23,300,000
$2M Securities Purchase Agreement [Member] | July 25, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 17,518
Accrued Interest Converted
Total Converted	$ 17,518
Conversion Rate	$ 0.0007
Common Shares Issued	24,500,000
$2M Securities Purchase Agreement [Member] | August 3, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 17,738
Accrued Interest Converted
Total Converted	$ 17,738
Conversion Rate	$ 0.0007
Common Shares Issued	25,800,000
$2M Securities Purchase Agreement [Member] | August 10, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 17,919
Accrued Interest Converted
Total Converted	$ 17,919
Conversion Rate	$ 0.0007
Common Shares Issued	27,150,000
$2M Securities Purchase Agreement [Member] | September 19, 2016 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 11,482
Accrued Interest Converted
Total Converted	$ 11,482
Conversion Rate	$ 0.0008
Common Shares Issued	14,912,185
$2M Securities Purchase Agreement [Member] | January 10, 2017 [Member]
Debt Instrument [Line Items]
Principal Converted	$ 41,121
Accrued Interest Converted	879
Total Converted	$ 42,000
Conversion Rate	$ 0.0014
Common Shares Issued	30,000,000
$2M Securities Purchase Agreement [Member] | January 18, 2017 [Member]
Debt Instrument [Line Items]
Principal Converted
Accrued Interest Converted	28,795
Total Converted	$ 28,795
Conversion Rate	$ 0.0045
Common Shares Issued	6,398,894

Third Party Debt (Details Textu

Third Party Debt (Details Textual) - USD ($)	Dec. 15, 2015	Dec. 10, 2015	Aug. 13, 2015	Aug. 12, 2015	Aug. 05, 2015	Feb. 10, 2015	Dec. 03, 2014	Apr. 19, 2016	Aug. 26, 2015	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Jun. 30, 2015	Mar. 31, 2016	Jun. 30, 2016	Jun. 30, 2015	Sep. 30, 2015	Mar. 07, 2016
Debt Instrument [Line Items]
Unsecured convertible promissory note principal amount						$ 1,808,000
Original issue discount																	$ 800,000
Aggregate principal amount			$ 800,000
Interest expense related to notes payable										$ 4,550					$ 13,108
Amortized discount to interest expense										5,106			$ 7,657		20,418	$ 17,866
Convertible notes payable, long-term										182,833					182,833		300,156
Interest expense										408,419			112,690		1,727,304	284,168
Loss on debt extinguishment			40,000										(6,924)			(26,905)
Total unamortized discounts										13,833					13,833
Convertible notes payable			655,816
Derivative liability										724,729					724,729		1,672,726
Convertible notes payable, current										251,961					251,961		522,396
Investor [Member]
Debt Instrument [Line Items]
Amortized discount to interest expense										15,000					15,000
Unamortized current										15,000					15,000
Fair value of derivative liability		$ 114,611
Gain on the change in fair value of the derivative liability										10,670					10,670
Derivative discount		$ 90,000
Total unamortized discounts										75,000					75,000
Conversion, description		The Investor purchased $90,000 in common stock at a purchase price equal to 90% of the average of the closing prices of the common stock for the three (3) trading days immediately preceding the date that is 6 months from the date of the agreement. As of June 7, 2016, the Company entered into an agreement for proceeds of $90,000 to be recorded as a convertible note payable with a conversion feature of 55% of the lowest trading price for the prior twenty (20) days.
Fair value of embedded conversion feature		$ 24,611
Purchase price of common stock		$ 90,000
Convertible Debt [Member]
Debt Instrument [Line Items]
Accrued interest										22,632					22,632
Interest expense										2,255			14,156		21,094	32,511
Convertible Note Financing [Member]
Debt Instrument [Line Items]
Original issue discount				$ 5,000	$ 12,500
Amortized of debt issuance costs										3,280					13,120
Aggregate principal amount				$ 105,000	541,000
Amortized discount to interest expense										1,000					4,000
Long term debt issuance costs										107,833					107,833
Maturity date				Jun. 12, 2016
Accrued interest										16,366					16,366
Interest expense				$ 20,000							$ 7,806			$ 7,806
Unamortized discount										17,167					17,167
Fair value of derivative liability				110,669
Gain on the change in fair value of the derivative liability										(237,246)					38,179
Derivative discount				103,000						51,500					85,833
Loss on debt extinguishment				$ 7,669
Accrued interest expense										7,769					15,222
Conversion, description				The convertible note bears interest at the rate of 8% per annum and is convertible into common stock of the Company at any time after 180 days from issuance of the note at a conversion price per share equal to 58% of the average of the lowest trading price of the common stock in the thirteen (13) trading days immediately preceding the applicable conversion date. The Company has the option to prepay the convertible note in the first 180 days from closing subject to a prepayment penalty of 150% of principal plus interest. The maturity date of the convertible note is June 12, 2016 subject to the noteholder's right to extend maturity an additional nine (9) month period.
Derivative liability										148,847					148,847
Convertible notes payable, current																		$ 112,000
August 2015 Notes [Member]
Debt Instrument [Line Items]
Original issue discount					9,374
Amortized of debt issuance costs										17,964					53,891
Amortized discount to interest expense										205,284					313,020
Convertible notes payable, long-term										61,167					61,167
Accrued interest										53,241					53,241
Interest expense										23,807					46,944
Fair value of derivative liability					1,181,732
Gain on the change in fair value of the derivative liability										1,235,526					839,257
Derivative discount					419,626
Total unamortized discounts										105,381					105,381
Accrued interest expense										2,764					5,890
Derivative liability										342,474					342,474
Convertible notes payable, current					419,626					163,219					163,219
Fair value of embedded conversion feature					762,106
August 2015 Notes [Member] | Investor [Member]
Debt Instrument [Line Items]
Amortized of debt issuance costs										500					1,000
Proceeds from issuance of debt	$ 50,000
Amortized discount to interest expense										3,422					3,422
Interest expense	11,600														5,605
Unamortized discount										61,178					61,178
Fair value of derivative liability	95,251
Gain on the change in fair value of the derivative liability										9,630					9,630
Derivative discount	61,600														4,000
Accrued interest expense										3,757					5,605
Derivative liability										85,621					85,621
Convertible notes payable, current										422					422
Fair value of embedded conversion feature	$ 33,651
Term of convertible note	2 years
Assigned 2015 Notes [Member]
Debt Instrument [Line Items]
Amortized of debt issuance costs										0					8,571
Aggregate principal amount					112,000
Amortized discount to interest expense										74,667					112,000
Accrued interest										12,562					12,562
Fair value of derivative liability					400,722
Gain on the change in fair value of the derivative liability										516,101					223,098
Derivative discount					112,000
Loss on debt extinguishment					$ 288,722
Accrued interest expense										3,219					12,066
April 2016 Note [Member]
Debt Instrument [Line Items]
Aggregate principal amount								$ 176,150
Amortized discount to interest expense										45,505					45,505
Maturity date								Jan. 19, 2017
Interest expense										5,711					5,711
Derivative discount								$ 91,011
Total unamortized discounts										45,505					45,505
Accrued interest expense															5,711
Conversion, description								The convertible note bears interest at the rate of 10% per annum and is convertible into common stock of the Company at any time after 180 days from issuance of the note at a conversion price per share equal to 55% of the lowest trading price in the thirteen (20) trading days immediately preceding the applicable conversion date. The Company has the option to prepay the convertible note in the first 180 days from closing subject to a prepayment penalty of 150% of principal plus interest. The maturity date of the convertible note is January 19, 2017. The Company recorded the prepayment penalty of $91,011 as a discount to the convertible note and will amortize it through the notes maturity date.
Convertible notes payable, current										130,645					130,645
Bears interest rate								10.00%
Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Unsecured convertible promissory note principal amount							$ 560,000
Original issue discount							50,000
Amortized of debt issuance costs															45,940
Transaction expenses (costs)							10,000
Aggregate principal amount							500,000			477,865					477,865
Finder's fee							25,000
Proceeds from issuance of debt							$ 475,000				21,874			21,874
Interest expense related to notes payable												$ 105,000
Amortized discount to interest expense										5,556			8,333		22,222	19,444
Fair value of derivative liability									$ 830,921
Gain on the change in fair value of the derivative liability										574,381					(287,888)
Derivative discount									332,666
Loss on debt extinguishment									$ 498,254
Conversion, description									Company and Investor entered into an Amendment whereby the conversion rate of the note was amended to 55% of the lowest price of the prior fifteen (15) trading days and conversion floor removed which amendment was triggered by the dilutive issuances of the August 2015 convertible note financing thereby entitling Investor to the lowest conversion rate granted during the year ended September 30, 2015 per the terms of the Securities Purchase Agreement.
Derivative liability										22,507					22,507
Total loss on debt extinguishment									$ 582,254
$2M Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Unsecured convertible promissory note principal amount						2,000,000
Original issue discount						182,000											148,600
Transaction expenses (costs)						$ 10,000											$ 651,395
Aggregate principal amount			2,000,000							632,629					632,629
Amortized discount to interest expense										0					472,628
Interest expense											$ 36,038			$ 36,038
Unamortized discount			94,184
Fair value of derivative liability			970,956
Derivative discount			655,816							(296,142)					27,730
Loss on debt extinguishment			$ 315,140
Conversion, description			The conversion rate of the note was amended to 55% of the lowest price of the prior fifteen (15) trading days and conversion floor removed which amendment was triggered by the dilutive issuances of the August 2015 convertible note financing thereby entitling Investor to the lowest conversion rate granted during the year ended September 30, 2015 per the terms of the $2M Securities Purchase Agreement.
Total loss on debt extinguishment			$ 369,324
Allocated additional paid in capital in fair value										123,179					1,056,544
$2M Securities Purchase Agreement [Member] | Convertible Debt [Member]
Debt Instrument [Line Items]
Interest expense related to notes payable										7,617			10,111		16,209	14,500
Amortized discount to interest expense										0			$ 17,600		30,713	$ 22,400
Accrued interest										35,319					35,319
Securities Purchases Agreement Two [Member]
Debt Instrument [Line Items]
Amortized discount to interest expense										28,183					277,682
Allocated additional paid in capital in fair value										$ 401,128					$ 1,195,787

Related Party Debt (Details)

Related Party Debt (Details) - USD ($)	Dec. 10, 2015	Dec. 07, 2013	Jun. 30, 2016	Jun. 30, 2016	Sep. 30, 2015	Jun. 30, 2015	Nov. 27, 2013	Sep. 30, 2013
Related Party Debt (Textual)
Accrued interest			$ 139,929	$ 139,929	$ 46,337
Interest expense related to notes payable			$ 4,550	$ 13,108
Preferred stock, shares authorized			100,000,000	100,000,000	100,000,000		100,000,000
Aggregate principal amount			$ 251,961	$ 251,961	$ 522,396
Shareholder [Member]
Related Party Debt (Textual)
Accounts payable, related parties								$ 15,000
Accrued interest			2,330	2,330
Interest expense related to notes payable			228	686
Interest rate		6.00%
Maturity date		Dec. 1, 2016
Series B Preferred Stock [Member]
Related Party Debt (Textual)
Accrued interest						$ 36,001
Interest rate	8.00%
Term of convertible note	1 year
Common stock conversion basis	Series B Preferred Stock on a one-for-one (1:1) basis into shares of common stock of the Company at a fixed price per share of $0.01.
Common stock fixed price per share	$ 0.01
Preferred stock, shares authorized	30,000,000
Voting rights, description	Each share of Series B shall be entitled to five (5) votes for every one (1) vote entitled to each share of Common Stock.
Aggregate principal amount	$ 300,000		$ 300,000	$ 300,000
Equity investment by the investor, description	1) $50,000 from Hive Ceramics, LLC in new capital to the Company and 2) an amended and restated note for Hive Ceramics LLC in the amount of $250,000 for capital previously contributed which is soon to be due and payable.

Commitments and Contingencies (

Commitments and Contingencies (Details)	Dec. 10, 2016USD ($)	Dec. 15, 2014USD ($)	Jan. 31, 2015shares	Jun. 30, 2016USD ($)ft²$ / sharesshares	Jun. 30, 2015USD ($)	Dec. 31, 2014USD ($)	Jun. 30, 2016USD ($)ft²tradingdays$ / sharesshares	Jun. 30, 2015USD ($)	Dec. 01, 2016USD ($)	Sep. 30, 2015USD ($)shares	Mar. 31, 2015USD ($)shares
Commitments and Contingencies (Textual)
Leases rent expense							$ 2,500
Company leases for office | ft²				2,500			2,500
Lease expiration date							Dec. 31, 2017
Warrant liability										$ 31,401
Fair value of warrant liability				0			0
Gain on change in warrant liability							31,401	$ 2,156,203
Gain on settlement								625,461
Proceeds from legal settlements						$ 62,930		$ 62,930
Vendor credits on settlement						200,000
Total vendor credits on settlement						$ 325,000
Treasury stock, shares | shares				1,025,625			1,025,625			690,625
Treasury stock, value				$ 372,601			$ 372,601			$ 367,531
Warrant liability expiration date							May 31, 2016
Settlement liability amount				151,000			$ 151,000
Convertible Promissory Note				182,833			182,833			$ 300,156
Officer [Member]
Commitments and Contingencies (Textual)
Shares assigned to officers | shares			440,625
Treasury stock, shares | shares											440,625
Treasury stock, value											$ 367,531
LG Capital Funding [Member] | Subsequent Event [Member]
Commitments and Contingencies (Textual)
Gain on settlement	$ 300,000
Settlement liability amount									$ 151,000
Shareholders and Related Parties [Member]
Commitments and Contingencies (Textual)
Gain on settlement		$ 257,930
GHS Investments LLC [Member]
Commitments and Contingencies (Textual)
Settlement liability amount				$ 151,000			$ 151,000
Convertible note interest rate percentage				10.00%			10.00%
Debt instrument convertible threshold trading days | tradingdays							20
Convertible common stock discount percentage							45.00%
Convertible Promissory Note				$ 161,000			$ 161,000
Warrants [Member]
Commitments and Contingencies (Textual)
Shares issued, price per share | $ / shares				$ 7.25			$ 7.25
Warrants [Member] | Minimum [Member]
Commitments and Contingencies (Textual)
Shares issued, price per share | $ / shares				4.72			4.72
Warrants [Member] | Maximum [Member]
Commitments and Contingencies (Textual)
Shares issued, price per share | $ / shares				$ 7.25			$ 7.25

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) - Warrant [Member]	9 Months Ended
	Jun. 30, 2016USD ($)$ / sharesshares
WARRANTS
Warrants outstanding, Shares, Beginning balance | shares	1,184,726
Warrants issued, Shares | shares
Warrants exercised, Shares | shares
Option/ Warrents Cancelled/forfeited/expired | shares	(1,184,726)
Warrants outstanding, Shares, Ending balance | shares
Warrants outstanding, Weighted Average Price, Beginning balance | $ / shares	$ 0.114
Warrants issued, Weighted Average Price | $ / shares
Warrants exercised, Weighted Exercise Price | $ / shares
Warrants Cancelled/forfeited/expired, Weighted Average Price | $ / shares	0.114
Warrants Weighted Average Price, Ending Balance | $ / shares
Warrants outstanding, Weighted Average Remaining Contractual Term, Beginning	10 months 24 days
Warrants outstanding, Aggregate Intrinsic Value, Beginning balance | $	$ 739,812
Warrants outstanding, Aggregate Intrinsic value, Ending balance | $

Stockholders' Deficit (Details

Stockholders' Deficit (Details Textual) - USD ($)

Mar. 31, 2016

Apr. 01, 2014

Dec. 23, 2015

Dec. 21, 2015

Dec. 20, 2015

Nov. 25, 2015

Oct. 22, 2015

Jun. 19, 2014

Dec. 31, 2015

Jun. 30, 2016

Jun. 30, 2015

Feb. 29, 2016

Dec. 10, 2015

Sep. 30, 2015

Aug. 13, 2015

Nov. 27, 2013

Stockholders' Deficit (Textual)

Common stock, shares authorized

1,000,000,000

1,000,000,000

1,000,000,000

Preferred stock, shares authorized

100,000,000

100,000,000

100,000,000

Aggregate principal amount

$ 800,000

Common stock issued for services

$ 31,689

Treasury stock, value

372,601

$ 367,531

Issuance of common stock

31,689

$ 36,769

Sales and Marketing Expense [Member]

Stockholders' Deficit (Textual)

Fair value of the stock vested issuance

$ 30,000

General and Administrative Expense [Member]

Stockholders' Deficit (Textual)

Fair value of the stock vested issuance

$ 1,143

$ 547

$ 36,000

Series A Preferred stock [Member]

Stockholders' Deficit (Textual)

Shares issued during period

500,000

Common stock issued for services

Series B Preferred Stock [Member]

Stockholders' Deficit (Textual)

Preferred stock, shares authorized

30,000,000

Preferred stock, shares issued

Preferred Stock [Member]

Stockholders' Deficit (Textual)

Shares issued during period

500,000

Preferred stock, shares authorized

100,000,000

30,000,000

Convertible price, description

A one-time pro rata adjustment of up to ten-for-one (10-1) based upon the Company generating aggregate gross revenues over the two years of at least $8,000,000 (e.g. If the Company generates only $4,000,000 in aggregate gross revenues over the two year period then the convertible ratio will adjust to 5-1). In no event will the issuance convert into more than 5,000,000 shares of common stock of the Company.

Description of asset purchase agreement

Series A Shares are entitled to vote at a 15-1 ratio to Common Stock.

Allan Viernes [Member]

Stockholders' Deficit (Textual)

Restricted common stock issued, Shares

300,000

Shares issued, price per share

$ 0.024

Joe Andreae [Member]

Stockholders' Deficit (Textual)

Restricted common stock issued, Shares

130,000

Treasury stock, value

$ 3,120

Shares issued, price per share

$ 0.024

Justin Braune [Member]

Stockholders' Deficit (Textual)

Shares issued during period

3,000,000

Restricted common stock issued, Shares

250,000

Shares issued, price per share

$ 0.009

Payment of accrued wages

$ 2,375

$ 15,000

Kyle Tracey [Member]

Stockholders' Deficit (Textual)

Restricted common stock issued, Shares

130,000

Treasury stock, value

$ 1,170

Board of Directors [Member]

Stockholders' Deficit (Textual)

Restricted common stock issued, Shares

142,857

49,760

1,250,000

Shares issued, price per share

$ 0.008

$ 0.011

$ 0.024

Board of Directors [Member] | Michael Cook [Member]

Stockholders' Deficit (Textual)

Restricted common stock issued, Shares

1,250,000

Shares issued, price per share

$ 0.024

Payment of accrued wages

$ 3,000

Board of Directors [Member] | Kyle Tracey [Member]

Stockholders' Deficit (Textual)

Restricted common stock issued, Shares

2,083,333

Shares issued, price per share

$ 0.024

Payment of accrued wages

$ 50,000

Board of Directors [Member] | Joe Andreae [Member]

Stockholders' Deficit (Textual)

Restricted common stock issued, Shares

555,555

Shares issued, price per share

$ 0.024

Payment of accrued wages

$ 13,333

Employees [Member]

Stockholders' Deficit (Textual)

Restricted common stock issued, Shares

300,000

Treasury stock, value

$ 360

Benjamin Beaulieu [Member]

Stockholders' Deficit (Textual)

Restricted common stock issued, Shares

300,000

Shares issued, price per share

$ 0.024

Benjamin Beaulieu [Member] | Allan Viernes [Member]

Stockholders' Deficit (Textual)

Restricted common stock issued, Shares

30,000

Treasury stock, value

$ 420

Intellectual Property (Details)

Intellectual Property (Details) - USD ($)	Jun. 30, 2016	Sep. 30, 2015
Intellectual Property (Textual)
Trademarks	$ 123,150	$ 123,150
Trademarks [Member]
Intellectual Property (Textual)
Trademarks	$ 123,150

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Nov. 01, 2016	Dec. 10, 2015	Oct. 28, 2016	Aug. 26, 2015	Jun. 30, 2016	Sep. 30, 2015	Aug. 13, 2015	Dec. 03, 2014
Subsequent Event Textual [Abstract]
Original principal amount							$ 800,000
Original issue discount						$ 800,000
Common stock, par value					$ 0.00001	$ 0.00001
HIVE Ceramics, LLC [Member] | Secured Series B Preferred Stock One [Member] | Convertible Promissory Note [Member]
Subsequent Event Textual [Abstract]
Original principal amount		$ 50,000
Interest rate		8.00%
Maturity date		Dec. 10, 2016
HIVE Ceramics, LLC [Member] | Secured Series B Preferred Stock Two [Member] | Convertible Promissory Note [Member]
Subsequent Event Textual [Abstract]
Original principal amount		$ 250,000
Interest rate		8.00%
Maturity date		Feb. 27, 2016
Maturity date, description		The Amended Note amended, restated, modified and superseded that $250,000 Promissory Note, dated March 27, 2014, entered into by and between the Company and Holder, which note had a principal of $250,000 and a maturity date of February 27, 2016. The Amended Note carried an interest rate of 8.0%. The Amended Note was due and payable by the Company on December 10, 2016 (the "Maturity Date").
Securities Purchase Agreement [Member]
Subsequent Event Textual [Abstract]
Original principal amount					$ 477,865			$ 500,000
Original issue discount								50,000
Transaction fee								$ 25,000
Description of conversion price				Company and Investor entered into an Amendment whereby the conversion rate of the note was amended to 55% of the lowest price of the prior fifteen (15) trading days and conversion floor removed which amendment was triggered by the dilutive issuances of the August 2015 convertible note financing thereby entitling Investor to the lowest conversion rate granted during the year ended September 30, 2015 per the terms of the Securities Purchase Agreement.
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Typenex Co-Investment, LLC [Member]
Subsequent Event Textual [Abstract]
Original principal amount	$ 1,413,000
Interest rate	10.00%
Original issue discount	$ 128,000
Transaction fee	$ 5,000
Description of tranches	The investment from Typenex is scheduled to occur in a series of sixteen (16) tranches, represented each by a separate Secured Investor Promissory Note (the "Tranche Notes") in varying amounts.
First Tranche Note	$ 40,000
Common stock, par value	$ 0.00001
Description of conversion price	The Conversion Price is as described in the Typenex Agreement and is based on at least a 45% discount to the trading price of the Company's common stock.
Membership interest, percentage	40.00%
Subsequent Event [Member] | Securities Purchase Agreement [Member] | GHS Investments, LLC [Member]
Subsequent Event Textual [Abstract]
Issuance of convertible securities			$ 1,105,000
Interest rate			10.00%
Original issue discount			$ 100,000
Transaction fee			$ 5,000
Description of tranches			The closing of the GHS Purchase Agreement, GHS funded $40,000 to the Company (the "Initial Tranche"). Within 15 days of certain conditions being met, an additional $40,000 shall be disbursed by GHS to the Company, in its sole discretion ("Second Tranche"). Within 30 days from the Second Tranche's issuance, so long as there are no defaults under the GHS Note, GHS in its discretion may fund an additional $50,000 to the Company every 30 days ("Subsequent Tranches") until $1,000,000 has been funded to the Company.
Common stock, par value			$ 0.00001
Description of conversion price			The Conversion Price is as described in the GHS Purchase Agreement and is based on at least a 45% discount to the trading price of the Company's common stock.